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 This single-case design study examined the effectiveness of adapting evidence-based 
treatments (EBTs) for children in a community clinic through a university-community 
partnership. Community clinic therapists treated eight youths (five males), ages 10 to 14, of 
whom four were Caucasian, two were Latino, one was African-American, and one was 
Caucasian/African-American. Youths presented with a primary diagnosis of a DSM-IV 
(American Psychiatric Association, 1994) internalizing disorder (plus multiple 
comorbidities). An adapted treatment combining multiple elements based on two primary 
treatment manuals: Coping Cat (Kendall et al., 1990) and PASCET (Weisz et al., 1999) was 
used. Youths with comorbid externalizing symptoms were also treated with elements from a 
parent-training manual (Barkley, 1997). Results of visual and clinical significance analysis 
demonstrated mixed support for the adapted treatment in a community clinic setting. The 
  
findings support further efforts to test the effectiveness of adapted EBTs in a community 
clinic setting and population. 
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Adapting Evidenced-Based Treatments For Youth in a Community Mental Health Setting: 
Single Case Design 
 
 Epidemiological data suggest a strong need for high quality mental health services to 
help the many youths with impairing mental health problems. According to the Surgeon 
General’s Report on Mental Health, one in five children in the United States are affected by 
the signs and symptoms of a Diagnostic and Statistical Manual of Mental Disorders, Fourth 
Edition, Text Revision (DSM-IV-TR), mental health disorder over the course of one year 
(American Psychiatric Association [APA], 2000). Other epidemiological studies indicate that 
the overall prevalence of childhood mental health disorders ranges from 14 percent to 26 
percent (Fergusson, Horwood, & Lynskey, 1993; U.S. Public Health Service [Surgeon 
General], 2000; Hoagwood & Olin, 2002).  
 Fortunately, there is a relatively strong and growing evidence base of child/adolescent 
mental health treatments (e.g., Chorpita & Daleiden, 2009). Multiple efficacious treatments 
have been tested for many of the mental health problems which children experience, 
including anxiety, depression, and disruptive behavior disorders. Thus, there has been 
optimism in the field about transporting these treatments into multiple service settings. 
However, as will be discussed shortly, progress on the path to widespread dissemination has 
been inconsistent. The study proposed here represents an effort to identify methods to move 
the field further down the path toward a better integration of science and practice. 
 To place the proposed study in the context of the current state of the science, several 
literatures will be examined.  First, the evidence bases for these three problem areas, given 
their commonness, are briefly and selectively reviewed. Next, I will discuss that despite the 
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optimism, evidence from effectiveness trials has suggested that these evidence-based 
treatments (EBTs) do not always fare well as would be expected (e.g., Southam-Gerow et al., 
2010; Weisz et al., 2009). Afterward, the many proposed barriers as to why these treatments 
have “struggled” in multiple service settings will be presented. Different ways for remedying 
this problem have been suggested; particularly partnership models have been proposed as a 
viable solution to aid in the implementation and dissemination of EBTs. Finally, I will 
describe the Chesterfield-VCU Adaptation of Depression and Anxiety Psychological 
Treatments for Youth (ADAPT) study, which implements a university-community 
partnership model in order to adapt EBTs in a public mental health context. 
Evidence-Based Treatment Review 
 The following review provides an illustrative overview of the evidence-based 
treatment literature for youth internalizing (i.e., anxiety disorders, depressive disorders) and 
externalizing disorders (i.e., disruptive behavior disorders).  
 Internalizing disorders, such as anxiety and depression, are some of the most 
commonly diagnosed mental health problems that children and adolescents experience 
(Southam-Gerow & Chorpita, 2007). Some studies suggest that anxiety symptoms and 
disorders may even be the most prevalent category, with up to 13 percent of children and 
adolescents suffering from at least one anxiety disorder (Silverman, Pina, & Viswesvaran, 
2008; Costello, Egger, Angold, 2005; Bernstein & Borchardt, 1991). Somewhere between 6 
percent (Fergusson et al., 1993) and 11 percent (McGee, Feehan, Williams, Partridge, Silva, 
& Kelly, 1990) suffer from mood disorders and lifetime rates for unipolar depression are 
approximately 20% (Lewinsohn, Rohde, & Seeley, 1998; Lewinsohn & Essau, 2002; 
Rudolph, Hammen, & Daley, 2006).  
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 Anxiety disorders cause children and adolescents to feel frightened, distressed and 
worried for no apparent reason. Although most children and adolescents experience fears and 
worries, the fears and worries that are present in anxiety disorders actually impede daily 
activities or functioning (Christophersen & Mortweet, 2001). Anxiety disorders include: 
separation anxiety disorder (SAD), panic disorder (PD), agoraphobia, generalized anxiety 
disorder (GAD), social phobia/social anxiety disorder, specific phobia, obsessive-compulsive 
disorder (OCD), posttraumatic stress disorder (PTSD), and acute stress disorder. Although 
the predominant feature of all these disorders is the emotion of anxiety, they are each 
distinguished by the focus of the child’s anxiety (Southam-Gerow & Chorpita, 2007). The 
evidence base for the treatment of childhood anxiety disorders is one of the largest and 
strongest in the child/adolescent treatment literature (Chorpita & Southam-Gerow, 2006). 
Behavioral and Cognitive Behavioral Therapy (CBT) are the most studied and best supported 
treatments for helping youth who have been diagnosed with an anxiety disorder (Chorpita & 
Southam-Gerow, 2006; Silverman et al., 2008). For example, CBT has been tested and found 
to be effective for anxiety disorders in youth in over 25 separate randomized trials 
(Silverman et al., 2008). Gradual exposures (in vivo or imaginary), coping plans, cognitive 
skills, relaxation, modeling, and psychoeducation comprise the main components of most 
CBT treatments (Silverman et al., 2008; Chorpita & Daleiden, 2009). Most versions of 
behavioral therapy and CBT also include parental involvement, in some cases, involving the 
parents in all sessions with their child. Behavioral therapy and CBT can be administered in 
individual and group settings (Chorpita & Southam-Gerow, 2006; Silverman, et al., 2008). 
They have also been delivered with good effects in schools, clinics, hospitals, day care 
centers, and even in homes; and evidence supporting CBT has been found across a variety of 
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racial and ethnic groups, including Caucasian, African American, Hispanic/Latino, Asian, 
and Multiethnic (see Silverman et al., 2008). 
  Similarly to anxiety disorders, the youth mental health treatment literature also 
identifies many well-established EBTs for depressive disorders. Depression can cause 
feelings of hopelessness, guilt, and/or sadness in children and adolescents. Common 
symptoms of depressive disorders in youth include: sadness; decreased energy and interest in 
activities; irritability; changes in sleep and appetite; difficulty in thinking clearly, making 
decisions, and concentrating; lethargy and/or fidgetiness; and thoughts of death or suicide 
(DSM-IV-TR; APA, 2000). Depressive disorders increase in adolescence and rates for girls 
double those found for boys in adolescence (Costello, Erkanli, & Angold, 2006; Angold, 
Erkanli, Silberg, Eaves, & Costello, 2002). Primary depression diagnoses for youth include 
major depressive disorder (MDD) and dysthymia. The evidence base shows that there are 
well-established EBTs for MDD and dysthymia in youth, specifically CBT and interpersonal 
therapy (IPT) (see David-Ferdon & Kaslow, 2008). In a recent review of treatments for youth 
depression, CBT was found to be efficacious in over 20 separate randomized trials (David-
Ferdon & Kaslow, 2008). CBT for depression focuses on identifying thoughts and behavioral 
patterns that lead to or maintain the problematic symptoms. For example, identifying 
negative beliefs, evaluating the evidence for these beliefs, and generating more realistic 
alternate thoughts. IPT for depression focuses on addressing the adolescent’s interpersonal 
communication skills, interpersonal conflicts, and family relationship problems. Overall, the 
most common practice elements found in effective treatments for youth with depressed mood 
are cognitive skills, psychoeducation, maintenance, relapse prevention, activity scheduling, 
problem solving, and self-monitoring (Chorpita & Daleiden, 2009). Research has indicated 
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that treatment gains occurred, regardless of where treatment was provided (i.e., school, 
community clinics, primary care clinics, hospitals, or research settings) or regardless of how 
the treatment was delivered (i.e., group, individual, or family therapy). Age appears to 
moderate treatment effects, with studies showing treatments are more effective for older 
adolescents than for children or younger adolescents (see David-Ferdon & Kaslow, 2008). 
There is also evidence that EBTs for youth depression might not be as efficacious for ethnic 
minority youth compared to Caucasian youth (e.g., Rohde et al, 2006; Cardemil et al., 2002). 
 Although internalizing disorders are common in children and adolescents, 
externalizing disorders like oppositional defiant disorder (ODD) and attention-deficit 
hyperactivity disorder (ADHD) represent the majority of referrals to mental health clinics 
(Loeber, Burke, Lahey, Winters, & Zera, 2000). Externalizing disorders are shown to be 
present in about 5 percent to 10 percent of children (Fergusson et al., 1993; McGee et al., 
1990; Costello, Mustillo, Erkanli, Keeler, & Angold, 2003). Disruptive behavior disorders 
(DBDs) are defined by the presence of a persistent pattern of negative, defiant, or rule 
breaking behaviors that are disruptive to the youth’s social, academic, familial, or personal 
functioning. DBDs include oppositional defiant disorder (ODD), and conduct disorder (CD). 
ODD is characterized by a pattern of negativistic, disobedient, and hostile behaviors, 
whereas, CD consists of more severe antisocial and aggressive behavior that may involve 
serious violations of other’s personal rights (McMahon & Frick, 2007). Attention deficit 
hyperactivity disorder (ADHD) is characterized by multiple symptoms of persistent and 
dysfunctional patterns of overactivity, impulsiveness, inattention and distractibility (Murphy, 
Cowan & Sederer, 2001).  
EBTs for DBDs and ADHD have also been identified (e.g. Eyberg, Nelson, & Boggs, 
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2008; see also Pelham & Fabiano, 2008). In contrast to EBTs for internalizing disorders (i.e., 
anxiety, depression), which are usually child-focused and primarily follow the cognitive-
behavioral theoretical approach, EBTs for externalizing disorders (i.e., ADHD, ODD, CD) 
apply social-learning and ecological systems theories, with greater focus on family and 
community involvement. For example, current research suggests that combined behavioral 
and pharmacological treatment is the most effective treatment for ADHD (Pelham & 
Fabiano, 2008). Classroom management strategies and behavior parent training are 
considered the most efficacious of the behavioral approaches (see Pelham & Fabiano, 2008). 
These programs use contingency management strategies (e.g., point/ token reward systems, 
time-out, response cost) to reinforce appropriate behavior and reduce unwanted behaviors. 
CBT programs for adolescents with ADHD may incorporate self-verbalization and problem 
solving strategies. Multimodal approaches that address functioning across multiple settings 
(e.g., home and school) have received the strongest support in the literature. For treatment of 
DBDs, behavioral parent management training has a strong evidence base (Eyberg et al., 
2008). Research indicates that for adolescents, use of behavioral parent management training 
should be one component of an approach that would also include on (a) bolstering 
adolescents’ coping skills and (b) strengthening the families’ communication and problem 
solving skills (see Eyberg et al., 2008). Very few studies have included ethnic minorities, 
children from low SES families, and girls (Pelham & Fabiano, 2008).  Studies that have 
included these participants suggest that low-income or minority families respond not as well 
to behavioral treatments compared to Caucasian families; no gender effects have been found 
(Arnold et al., 2003). In conclusion, EBTs for externalizing disorders place greater emphasis 
on parent training and community involvement than EBTs for internalizing disorders.  
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Transporting EBTs into Community Settings 
 The brief illustrative review demonstrates the promise of several psychosocial 
treatments for both internalizing and externalizing disorders leading to optimism that 
disseminating these efficacious treatments into multiple service settings such as community 
clinics would lead to improved outcomes for youths and families (e.g., Weisz et al., 1995). 
Unfortunately, despite the optimism, EBTs are not being consistently used in these settings 
(Norquist, Lebowitz, & Hyman, 1999; Street, Niederehe, & Lebowitz, 2000; Weiss, Catron 
& Harris, 2000; Kazdin, 2000). Further, until recently, few efforts have been made to study 
the effectiveness of these treatments in these settings and of the few studies that have 
attempted, evidence has been mixed (Hoagwood & Olin, 2002; Clarke, Hornbrook, Lynch, 
Polen, Gale, O’Connor, et al., 2002; Chorpita et al., 2002; Addis, Hatgis, Krasnow, Jacob, 
Bourne, & Mansfield, 2004; Martin, Herie, Turner, & Cunningham, 1998). In the next 
section, I will discuss important key terms used in dissemination research. Then, I will 
review those studies testing the effectiveness of EBTs in diverse community contexts.  
The issue of efficacy versus effectiveness has become an integral part of 
psychotherapy literature in the past two decades. Although they often share a common goal 
of testing psychotherapy treatments in the hopes of increasing positive outcomes and 
functioning for people suffering from mental illness, they differ in many ways. According to 
Nathan, Stuart, & Dolan (2000), efficacy studies maximize internal validity, are carefully 
controlled outcome studies, use homogenous patient samples, implement random assignment 
of participants, and, often, investigate manual-based, time-limited treatments. Efficacy 
studies also regularly take place in research settings. Once efficacy studies have provided 
supportive data, the treatment moves to the next stage: effectiveness studies (Southam-
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Gerow, Marder, & Austin, 2008).  
Effectiveness studies aim to be externally valid by generally testing treatments in real-
world clinical settings. To maximize external validity and reflect real-world clinical settings, 
these studies are often less controlled, include more heterogeneous samples, and usually use 
non-random assignment. Effectiveness studies measure outcomes under conditions of high 
external validity and aim to determine whether treatments, which have been shown to be 
efficacious, are effective across broad populations and settings (Nathan et al., 2000). Once 
effectiveness studies have demonstrated positive outcomes outside of controlled research 
settings, an intermediate step between effectiveness and dissemination has been suggested 
(Southam-Gerow et al., 2008). Transportability studies focus on identifying certain key 
strategies needed to encourage the adoption and effective implementation of innovations (i.e., 
psychosocial treatments) in multiple settings. Implementation is described as a specific effort 
to make a program or treatment work across settings (e.g., community settings). 
Dissemination, on the other hand, focuses on how a treatment is marketed after the means for 
implementing the treatment successfully have been identified (Southam-Gerow et al., 2008).  
 Recently in the youth psychotherapy literature, there has been an increased effort to 
implement EBTs for youth into community service settings. Here I look at the several ways 
researchers have attempted to examine the impact of both internalizing and externalizing 
disorder EBTs in non-research settings. For internalizing disorder EBTs, benchmarking 
studies, a meta-analysis of usual care, and effectiveness trials have contributed to the 
evidence base on dissemination efforts. For example, Weersing & Weisz (2002) used a 
benchmarking strategy to compare usual care treatment for youth with depression in a 
community clinic to CBT clinical trial outcomes. A benchmarking strategy involves 
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comparing outcome data obtained in a practice context with outcomes established for the 
same treatment in clinical trials. The community sample contained a higher proportion of 
ethnic minority youth and had a higher rate of comorbidity, similar to the findings in other 
studies, which showed differences between youth in community clinics versus research-
based settings (e.g., Southam-Gerow, Chorpita, Miller, & Gleacher, 2008; Southam-Gerow, 
Weisz, & Kendall, 2003). Results showed that the community youth sample outcomes more 
closely resembled treatment outcomes of youth in the randomized controlled trial’s (RCTs) 
control conditions rather than the youth in the RCTs CBT conditions. Youth in the 
community usual care sample took twice as long to reach a similar level of symptom relief 
than the youth treated with CBT. This study showed that CBT for depression had a 
significant advantage over community usual care treatment, hence supporting the notion to 
increase dissemination efforts of EBTs into community service settings.  
 Other benchmarking studies have shown that similar outcomes can be obtained when 
EBTs are transported to community service settings versus controlled research trials. For 
example, Weersing, Iyengar, Kolko, Birmaher, & Brent (2006) compared CBT treatment in 
an outpatient depression specialty clinic to a “gold standard” CBT RCT for depression (see 
Brent et al., 1997). The outpatient clinic sample had a higher rate of suicidality than the 
benchmark sample, as well as a higher rate of comorbidity. Results indicated that the 
outpatient youth outcomes were as favorable as the RCT, albeit the outpatient youths showed 
slower improvement. Comorbidity or suicidality were not significant factors in treatment 
outcomes indicating the robustness of the treatment across complicating factors. Another 
benchmarking study that compared school based CBT for depression to results from prior 
efficacy trials of the same treatment also showed support for the transportability of EBTs into 
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community service settings. Shirk, Kaplinksi, & Gudmundsen (2008) found that school based 
CBT outcomes were comparable to the results in efficacy trials and actually better than an 
efficacy trial with the original manual and a prior school based CBT trial. Positive outcomes 
were robust across age, gender, and ethnic groups as well as with youth with comorbid 
symptomatology. Overall, benchmarking studies have indicated positive outcomes for EBTs 
in community settings above usual care treatment, supporting recent transportability and 
implementation efforts. 
Other studies have also shown support for transporting EBTs into non-research based 
settings. A meta-analysis of 32 randomized trials that compared EBTs to usual care for youth 
therapies found that EBTs outperformed usual care (Weisz, Jensen-Doss, & Hawley, 2006). 
Results indicated a mean effect size of .30, which falls within the range of small to medium 
effects (Cohen, 1988), and effect size was not reduced by high levels of severe 
symptomatology or by inclusion of ethnic minority youths. However, five studies included in 
the meta-analysis indicated that usual care was better than EBTs. The meta-analysis gives 
support for the dissemination of EBTs, but the authors suggest that effect sizes could be 
larger if the treatments were strengthened by necessary adaptations.  
  Although the benchmarking studies and the meta-analysis show positive 
support for recent dissemination efforts, some effectiveness studies have shown no 
differences between EBTs and usual care. In 2005, Barrington and colleagues tested the 
effectiveness of cognitive-behavioral therapy (CBT) for childhood anxiety disorders against 
usual care in a community clinic setting using a randomized controlled trial (RCT) design. 
Participants (N = 54) ages 7 to 14 years old were randomly assigned to either the CBT group 
(n = 28) or the usual care group (n = 26). No significant group differences were found on 
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any measure and children in both groups improved over time. Southam-Gerow and 
colleagues (2010) also found no significant differences on symptom or diagnostic outcomes 
for a CBT treatment condition for childhood anxiety disorders versus usual care in several 
community clinics. Overall, the benchmarking studies support the transportability of EBTs, 
but these positives are not as clearly demonstrated in the meta-analysis (e.g. lower effect 
sizes) and the effectiveness trials. 
Studies comparing CBT for youth depression have also shown mixed evidence. For 
example, a recent RCT that compared CBT for depression to usual care in a community 
clinic found that the two treatment conditions did not differ in outcomes (Weisz et al., 2009). 
However, compared to usual care, CBT was briefer, superior in parent engagement, youth 
were less likely to require additional services, and it was less costly. Kerfoot, Harrington, 
Harrington, Rogers, and Verduyn (2004) studied the effectiveness of brief CBT for depressed 
adolescents delivered by social workers in the United Kingdom. Brief CBT was compared to 
routine care and no significant differences were found between the two groups on symptom 
and functioning outcome measures.  
Similarly to EBTs for internalizing disorders, effectiveness studies have also been 
used to test the applicability of EBTs for externalizing disorders in other service settings. 
According to Evans (2005) the “availability of cost-effective programs for children with 
ADHD in school settings has been well documented.” Due to the nature of externalizing 
disorder EBTs, many of them have initially been tested with effectiveness-type designs, 
making the move to dissemination smoother than internalizing disorder EBTs. Behavioral 
contingency management is already widely being used in school settings (Gottfredson & 
Gottfredson, 2001; Walker et al., 2003), and multisystemic therapy (MST; Henggeler, 
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Schoenwald, Borduin, Rowland, & Cunningham, 1998) programs have been well established 
in 32 states and 10 nations, hence supporting transportability efforts (Schoenwald, 2010). In 
this section, I will review specific externalizing disorder EBT programs that have shown 
positive outcomes in other service settings and are well established in the treatment literature.  
Multidimensional Treatment Foster Care (MTFC) is an example of an EBT for youth 
with severe and chronic delinquent behavior that has supported effectiveness in community 
settings (Eyberg et al., 2008). MTFC is a community-based program designed as an 
alternative to institutional-, residential-, and group-care placements. Two studies have found 
MTFC superior to usual group home care for adolescents with histories of chronic 
delinquency (Chamberlain & Reid, 1998; Leve, Chamberlain, & Reid, 2005). 
Another example is MST, an intervention approach for treating adolescents with 
serious antisocial and delinquent behavior (Henggeler et al., 2009). It combines treatments 
and procedures as needed to provide an intensive family and community-based intervention 
designed for the individual family, with the goal of promoting responsible behavior and 
preventing need for out-of-home placement (Eyberg et al., 2008). Studies with adolescents 
who committed criminal offenses found MST superior to usual community services as well 
as alternative community treatments (Borduin et al., 1995; Henggeler, Melton, & Smith, 
1992; Henggeler, Melton, Brondino, Scherer, & Hanley, 1997).  In conclusion, effectiveness 
studies for externalizing disorder EBTs have shown success when transported into other 
services settings.  
 Altogether, support for the potency of EBTs in community service settings has been 
mixed. Overall, evidence for the transportability of externalizing disorder EBTs has shown 
positive outcomes, and EBT programs have been well established in many diverse service 
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settings. On the other hand, evidence for the transportability of internalizing disorder EBTs is 
not as clear; benchmarking studies support positive outcomes for internalizing EBTs, but 
these outcomes are not as clearly shown in the meta-analysis and the effectiveness trials.  
Challenges to Transportability 
 A myriad of reasons have been identified to explain the science-practice gap and 
these mixed findings (Southam-Gerow, 2004; Weisz, 2000). Some have suggested that the 
research-based method of treatment development does not take into account the complexity 
of most community-based service clinic settings. In order to capture the complex nature of 
these settings, Schoenwald and Hoagwood’s model provides multiple levels of variables to 
consider when developing and adapting treatments; these levels include: (1) client level 
factors, (2) provider level factors, (3) clinic/agency level factors, and (4) service system level 
factors (2001). Considering these unique factors when adapting EBTs, will allow us to 
identify necessary adaptations at each level in order to improve transportability into a 
community service setting. For the purposes of the present study, I examine two of these in 
detail: (a) client level differences, and (b) therapist level differences. 
Client Level Differences  
One potential obstacle of transporting EBTs into community service clinics is related 
to a mismatch between the complexity of child problems and the focus of many EBTs. 
Development and testing of these efficacious treatments for children with mental health 
disorders has been conducted in university-based research settings, which may be different 
from community clinics. Many of the treatments are developed for children and adolescents 
that have a single DSM-IV diagnosis or at least the treatments focus on a single disorder or 
problem type. In contrast, many youth seen in community service clinic settings meet criteria 
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for more than one DSM-IV diagnosis (Southam-Gerow, Weisz, & Kendall, 2003; Bird, 
Gould, & Staghezza, 1993). Anxiety clinic research samples have been shown to be very 
similar across different settings, supporting the homogeneity of the populations used to study 
and test these treatments (Southam-Gerow et al., 2006). However, recent evidence has shown 
that there are a number of differences between clients seen in research versus service clinic 
settings that may affect the applicability of treatments in a community outpatient service 
clinic (Kazdin & Whitley, 2006; Schoenwald & Hoagwood, 2001). For example, children 
with internalizing disorders in community mental health clinics have significantly higher 
levels of externalizing comorbidity as compared to those seen in research clinic settings 
(Southam-Gerow et al., 2003). The focus on youth-only involvement for internalizing 
disorder EBTs may present a problem for the effectiveness of these interventions in service 
settings. Comorbidity is one of many complex factors that occur in clinic referrals (Kazdin, 
1995).  Fewer than 33% of children who are diagnosed with a depressive disorder solely 
experience depression; most of these children are diagnosed with another disorder, most 
commonly anxiety disorders or a disruptive behavior disorder (Angold & Costello, 1993; 
Hammen & Rudolph, 2003). Also, studies have shown that children with comorbid disorders 
show greater impairment at home, at school and in social settings (Kazdin & Whitley, 2006).  
Studies have found that comorbidity may not be relevant to treatment outcomes and 
may not limit the applicability of these treatments in service settings (Kazdin & Whitley, 
2006; Kendall, Brady, & Verduin, 2001; Southam-Gerow, Kendall, & Weersing, 2001). In 
contrast, Southam-Gerow and colleagues (2003) found that the comorbidity rates in these 
aforementioned study samples were different from those found in typical service clinics. 
Since many children in service settings present with comorbid externalizing 
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symptomatology, transportability of EBTs for internalizing disorders into these settings will 
be difficult due to the theoretical and structural differences (e.g. parental and community 
involvement) between internalizing disorder EBTs and externalizing disorder EBTs. 
Altogether, EBTs for internalizing disorders may need to be adapted and integrated into a 
more socio-ecological framework to improve chances of successful outcomes with youth 
experiencing externalizing symptomatology. Once adaptations occur, researchers may more 
easily move from efficacy research in research-based settings to seeing how these treatments 
function effectively in service settings.  
 Clients also appear to differ systematically between research and service contexts 
such that youths seen in service clinics possess multiple sociodemographic disadvantages, 
compared to youths seen in research clinics (Southam-Gerow et al., 2008; Southam-Gerow et 
al., 2003; Ehrenreich, Southam-Gerow, Hourigan, Wright, Pincus, & Weisz, in press). For 
example, a recent study found that public clinic youth were more likely to be a minority, 
have a lower socioeconomic status, and come from single-parent families (Southam-Gerow 
et al., 2003). Research has shown that practitioners in community clinics indicate that clients 
they see in these clinical settings have more severe symptomatology, more complex cases, 
and usually carry more than one diagnosis (Dulcan, 2005; Westen, Novotny, & Thompson-
Brenner, 2004; Kazdin & Whitley, 2006). Due to these differences seen in community 
clients, including a youth’s family as part of treatment is a reality in a community practice 
setting and many EBTs do not include parental involvement (Surgeon General, 2000; Kazdin 
& Whitley, 2006). In addition, differences in terms of therapist characteristics may also be 
present, further undermining the notion that the EBTs will be easily applied in diverse 
settings (e.g., Schoenwald & Hoagwood, 2001; Southam-Gerow, Hourigan, & Allin, 2009).   
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Therapist Level Differences  
Therapist level differences may also complicate efforts. For example, community 
service clinics employ a wider range of mental health providers (e.g., masters & PhD-level 
psychologists, bachelors & masters-level social workers, psychiatrists, nurses), with diverse 
educational training backgrounds that may not include training in evidenced-based practices 
(Smith-Boydston & Nelson, 2008; Addis & Krasnow, 2000). Most EBTs that have been 
developed in research settings are based in behavioral or cognitive-behavioral theory (CBT), 
whereas non-behavioral theoretical models (e.g., psychodynamic, family systems) have often 
guided treatment in community service settings (Weisz & Kazdin, 2003). Providers in 
research settings are also different than providers in community settings because the former 
are usually trained in a single protocol for one specific problem in the context of a federally-
funded research study, and see only those clients that meet certain criteria for the specific 
manual based treatment (Addis & Krasnow, 2000). Community providers on the other hand, 
are usually not trained on a specific manual and may use many different treatment techniques 
when interacting with youths and their families (Weisz et al., 2003). 
Due to these differing characteristics in education and training, many community 
mental health providers appear to have difficulty “buying in” to EBTs (Weisz et al., 2000). 
Community providers are at times critical of “cookbook” style manuals and feel that clinical 
judgment is a more appropriate tool for positive treatment outcomes (Levant, 2004; Dulcan, 
2005; APA Policy Statement on EBPP, 2005). Providers also feel that EBTs are less 
appropriate for their heterogeneous caseloads, which make it difficult to find manuals that 
meet the needs of their clinical populations (Henggeler et al., 1995; Chorpita & Donkervoet, 
2005). Research has also shown that there are few incentives for community practitioners to 
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learn new approaches, further increasing the difficulty to want to “buy in” to using EBTs in 
their clinical practice (Weisz et al., 2000). Hence, transportability and implementation efforts 
that do not consider differences in therapist characteristics between research-based settings 
and community clinics may have a more difficult time transporting EBTs in these settings. 
 Overall, there are a number of factors complicating the transportability of EBTs from 
research clinics to other contexts and we need to identify pathways to overcoming them. The 
current study represents one possible pathway to transportability and implementation, the use 
of a partnership model. In the next section, I will briefly identify the different ways that have 
been proposed as pathways of transportability and implementation, focusing on partnership 
models, before describing the current study.  
Solutions to Challenges 
 Efforts to test EBTs in diverse settings have been mixed, transporting EBTs directly 
from a research-based setting to a community service setting has not worked well, and thus 
attention to implementation methods that could improve transportability is warranted. Given 
the difficulties in transporting EBTs, some have advocated an intermediate step between (a) 
development of an efficacious treatment and (b) wide-spread dissemination (e.g., 
Schoenwald & Hoagwood, 2001). Different implementation techniques have been identified 
to guide transportability efforts into community settings (Schoenwald & Hoagwood, 2001; 
Southam-Gerow et al., 2008). For example, Weisz (2000) proposed the clinic-based 
treatment development (CBTD) model as a way to move EBTs from efficacy studies to 
effectiveness studies. CBTD sequences effectiveness studies to increasingly include 
populations, clinicians, and clinical settings of usual care circumstances (Schoenwald & 
Hoagwood, 2001). The clinic intervention development (CID) model adds onto CBTD by 
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also including practice setting variables (Hoagwood, Burns, & Weisz, 2002). Other 
implementation techniques have also been proposed to guide transportability efforts (see 
Southam-Gerow et al., 2008). In this next section, I will focus on the partnership model 
framework and discuss a university-community partnership for treatment adaptation. 
A Partnership Approach to Treatment Adaptation 
 One way proposed to implement EBTs and bridge the gap between science and 
practice is to develop and test EBTs in collaboration with community mental health clinics 
and adapt them in order to fit the needs of the client population in the community setting and 
treatment providers in the service clinic (Southam-Gerow et al., 2008). According to this 
perspective, the adaptation of these treatments will require greater levels of collaboration 
between researchers and community mental health stakeholders (Southam-Gerow, 2005). 
Models emphasizing collaborative relationships between researchers and community 
stakeholders have been in use for many years in fields such as education (e.g., Adelman & 
Taylor, 2004) and public health (e.g., Harper et al., 2004; Sullivan & Kelly, 2001); and more 
recently, mental health researchers have begun to use partnership models as a way to 
implement EBTs (Gotham, 2004; Hoagwood et al., 2002).  
 Participatory action research (PAR; Jason, Keys, Suarez-Balcazar, Taylor, & Davis, 
2004) was the partnership framework model used to aid the transportability and implement 
EBTs into a community mental health setting in the current study. PAR is a diverse set of 
strategies designed to empower and give voice to a group or groups of citizens, and to 
ultimately create social action (Taylor et al., 2004). The model involves research participants 
and consumers as collaborative partners in the decision-making process and seeks to create 
change at an organizational or systemic level. PAR allows all involved parties to have a say 
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(Middlestadt et al., 1997). Community stakeholder involvement is a key element in this 
framework, and our study aims to make this an important focus in the adaptive treatment 
process. The PAR framework will help us to find solutions to many of these proposed 
barriers (e.g., client- and therapist level differences) and allow us to successfully adapt and 
test a new treatment for child mental health problems in a community service setting. 
University-Community Partnership Approach 
 The present study is one component in a larger research project, the Chesterfield-
VCU Adaptation of Depression and Anxiety Psychological Treatments for Youth (ADAPT) 
study. ADAPT was designed to provide a preliminary test of the application of a partnership 
model in adapting EBTs in public mental health contexts. ADAPT exemplifies a university-
community partnership approach for treatment adaptation in the youth treatment literature 
(e.g., Southam-Gerow et al., 2009), and is a collaborative project aimed at adapting and 
implementing EBTs designed for youth with internalizing problems (i.e., anxiety and/or 
depression) and comorbid externalizing behavior problems for use in a public mental health 
setting. As stated previously, the presence of multiple, comorbid disorders may complicate 
transportability and implementation of EBTs because most treatment programs are designed 
to focus on a single problem. The ADAPT study, through a series of phases, attempts to 
develop and test a method for implementing EBTs for youth with multiple, impairing 
problems.  
 ADAPT is a mixed quantitative/qualitative project that consists of four phases: (a) 
preliminary focus groups, (b) single case series, (c) open trial, and (d) post-project focus 
groups. The current study draws on data from the second phase: the single-case series. The 
single-case series was designed as an initial step in adapting EBTs for internalizing disorders 
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(i.e., CBT) to address youth with comorbid externalizing symptomatology. In this sense, the 
single case phase was a small-scale transportability study since it aims, through treatment 
adaptation and implementation of the partnership model, to encourage the adoption of this 
treatment into a community setting. The study involved working in partnership with 
therapists to apply EBTs to cases identified to fit a particular profile (i.e., youth with 
internalizing and externalizing disorders). Although treatment for the youth was planned to 
follow EBTs, there was dialogue between researcher and the partner therapists to adapt and 
adjust the EBTs in response to therapist judgments. The goal of the single case series was to 
(a) demonstrate that adapted EBTs would lead to improvements in client functioning and (b) 
identify ways to formalize the adaptations into manual-like format for the third phase of the 
project. 
Justification of Single Case Design 
 Single case design was selected for the second phase of ADAPT because it will allow 
us to establish data on safety of our early attempts to adapt EBTs for youth with comorbid 
disorders, as well as provide preliminary evidence of positive effects, and aid in further 
adaptation of the treatment (Photos, Michel, & Nock, 2008; Southam-Gerow et al., 2009). 
Single-case design is appropriate for analyzing initial feasibility data (Nock et al., 2008). 
Although single case design has been used less often in the recent treatment literature, 
Kazdin (1982) states that it may be most relevant in treatment research because it allows for 
the observation of clinical change in an individual subject. It can also allow the researcher to 
see treatment differences in individuals that might get lost in tests of group differences 
(Sidman, 1960).  
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 Although single-case design is limited in the validity of references, threats to validity 
can be ruled out through repeated assessment. In our study, a multiple baseline design was 
used in order to establish a consistent baseline in the dependent variable before beginning 
treatment (Nock et al., 2008). In this case, threats to validity (e.g., regression to the mean, 
history, maturation) can be controlled and inferences about changes in data points as related 
to treatment progress can be made with greater confidence.  
 Visual inspection of graphed data points is the most commonly used and conservative 
method to analyze data in single-case design, relying on large changes in the measured data 
(Gaynor, Baird, & Nelson-Gray, 1999; Kazdin, 1982). Following a stable baseline 
measurement period, a researcher can identify changes in levels or trends of the data. Clinical 
significance analysis is another means of examining data in single-case design. Here 
normative data for the dependent measures is used as a base of comparison for subject scores 
(Kendall & Grove, 1988). A subject can be classified as treatment success/failure based on 
their status in comparison to normative data and if they are no longer in the dysfunctional 
range of scores after treatment. An outcome measure’s sensitivity to change, the degree to 
which a measure is likely to reflect changes that occur as a result of the intervention, is 
important to consider when identifying changes in trends of data (McClendon et al., 2011). 
Especially in cases when a participant’s scores never reach the dysfunctional range or when 
the change is not large enough to be clear. Reliable change index (RCI) is one way of 
identifying meaningful change in a participant’s data (Jacobson & Truax, 1991). RCI 
indicates whether change reflects actual clinical change on a measure as opposed to normal 
fluctuations in scores over time or measurement error. Using the RCI and the clinical cutoff 
cases can be categorized as: (1) recovered (passed clinical cutoff and RCI criteria), (2) 
 22 
improved (passed RCI criteria but not clinical cutoff), (3) unchanged (passed neither criteria), 
and (4) deteriorated (passed RCI criteria, but towards a worsening direction). 
 The proposed project applies multiple baseline single case design methods to test 
adapted EBTs for youth with internalizing disorders and comorbid externalizing 
symptomatology with a small sample of children (n = 8) from a community mental health 
clinic. Throughout treatment, assessments will be conducted across three phases: (a) 
Baseline, (b) Treatment, and (c) Follow-up. Both parent-report and youth self-report 
measures will be administered. Therapists in the community clinic who have been trained to 
use the adapted treatment will administer treatment.  
 It is hypothesized that treatment gains will be achieved for each individual enrolled in 
the single case series across parent and child reporters on both symptom and diagnostic 
measures for both internalizing and externalizing domains. It is also hypothesized that 
functioning will increase for each individual on global functioning measures indicating 
decreased impairment. The results of this single-case series will also add to the growing 
evidence base of the effectiveness of EBTs for youth in community service settings, and 
further support the use of partnership models to improve further implementation of mental 
health treatments in multiple service settings.   
Methods 
Participants & Screening Procedure 
 This study involved the participation of eight (n = 8) children (between the ages of 8 
and 14) and their families. Participants were recruited for the study from the outpatient 
referral pool of a community mental health clinic in a metropolitan area in the mid-Atlantic 
region of the United States. After an initial phone screening, families with children between 
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the ages of 7 to 16 who presented to the clinic with a problem consistent with a DSM-IV-TR 
(APA, 2000) diagnosis of Major or Minor Depressive Disorder, Dysthymic Disorder, 
Generalized Anxiety Disorder, Separation Anxiety Disorder, or Social Phobia were invited to 
an initial assessment. Effort was made to select participants such that an equal number had 
either a primary anxiety disorder or a depression disorder; in the end three children had an 
anxiety disorder as their primary target problem, and five children had a primary depressive 
disorder. Inclusion criteria for the study included: (a) the presence of one of the target 
disorders that merited treatment priority after the initial assessment and (b) presence of 
symptoms of either Oppositional Defiant or Conduct Disorder. Children with a diagnosis or 
symptoms of Attention Deficit/Hyperactivity Disorder (ADHD) were included if they were 
stabilized on an ADHD medication. Participants were excluded if they were currently taking 
any psychotropic medications (except for ADHD medication), and/or diagnosed with a 
Pervasive Developmental Disorder, Mental Retardation, or a psychotic disorder. 
 Twelve families completed the first baseline assessment. Of these 12 families, three 
families did not meet inclusion criteria and two families were lost to follow up. There were 7 
total families who completed treatment and at least one follow-up assessment. Participant 1 
was lost to follow-up, and due to a lack of data for comparison, this participant will not be 
included in the analyses. No adverse events were reported. See Table 1 for participant 
information. 
Table 1.   
Participant Demographics 
Participant 
Number 
 
Sex 
 
Age at 
Intake 
 
Ethnicity 
 
Intake 
Diagnosis 
 
# of Baseline 
Assessments 
 
# of 
Treatment 
Assessments 
# of Follow-
Up 
Assessments 
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Table 1 (continued)  
1 Male 11 Caucasian/ 
African-
American 
Minor 
Depression, 
Encopresis, 
ADHD 
4 1 0 
2 
 
Male 
 
12 
 
Caucasian 
 
Social 
Phobia 
 
3 
 
3 2 
 
3 Male 
 
10 
 
Caucasian 
 
Minor 
Depression, 
ADHD, 
ODD 
 
5 
 
5 2 
 
4 
 
Male 
 
12 
 
Caucasian 
 
Panic 
Disorder, 
Separation 
Anxiety 
Disorder 
 
3 
 
2 3 
 
5 
 
Female 
 
14 
 
Latino 
 
Minor 
Depression 
 
4 
 
2 3 
 
6 
 
Male 
 
11 
 
Caucasian 
 
Minor 
Depression, 
Enuresis, 
ADHD 
 
3 
 
3 3 
 
7 
 
Female 
 
12 
 
African-
American 
 
Simple 
Phobia, 
Social 
Phobia, 
GAD 
 
3 
 
 
1 4 
 
8 Female 14 Latino Major 
Depression 
1 1 1 
    
Measures  
 Measures were chosen based on the assessment model proposed by Hoagwood et al. 
(1996) that focuses on a broad range of possible treatment effects, including five domains of 
outcomes: (a) symptoms and diagnoses, (b) functioning, (c) consumer perspectives, (d) 
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environments, and (e) systems. For the present study, I focus on two domains (symptoms and 
functioning) because they are most relevant to the proposed goals of the study. See Table 2 
for single case series data collection schedule. 
Symptoms and diagnosis domain. 
 Schedule for Affective Disorders and Schizophrenia for School-Age Children-
Present and Lifetime Version (K-SADS-PL). (Kaufman, Birmaher, Brent, Rao, & Ryan, 
1997).  The K-SADS-PL is a semi-structured diagnostic interview that includes a screen 
interview and five diagnostic sections. The 82-item screen interview is used to eliminate the 
longer full diagnostic sections for those children that do not receive a threshold score on the 
screen interview. The diagnostic sections include (a) affective disorders, (b) psychotic 
disorders, (c) anxiety disorders, (d) behavioral disorders, and (e) substance abuse, eating, and 
tic disorders. Retest reliability across three weeks ranged from .63 to 1.00 for present 
diagnoses and from .55 to 1.00 for lifetime diagnoses (Kaufman et al., 1997). Interrater 
reliability was high ranging from .93 to 1.00 and concurrent validity was also fair to good 
across diagnostic categories. Psychometric data compare favorably with those reported for 
other diagnostic interviews (e.g., DISC, ADIS-C). Trained clinical psychology doctoral 
students administered the K-SADS-PL at intake and follow-up. Only parent report data was 
used to determine diagnosis at baseline and follow-up. 
 Child Behavior Checklist (CBCL). (Achenbach & Rescorla, 2001). Caregivers 
completed the CBCL, a widely used and extensively researched measure of demonstrated 
reliability and validity (see Achenbach & Rescorla, 2001). The CBCL’s 118-item problem 
portion is used to assess a broad range of symptoms. It yields scores for broadband 
internalizing and externalizing scales, as well as more focused narrow-band scales (e.g., 
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anxiety). Reliability for the CBCL is excellent with alphas ranging from .78 to .97 and retest 
reliability coefficients above .72. Achenbach & Rescorla recommend a one to two month 
interval between administrations (2004). It has been suggested that the CBCLs limited 
response range (i.e., not true, sometimes true, and often true) may affect the CBCLs 
sensitivity to change (Lipsey, 1990). A recent study indicated a broadband problems scale 
(i.e. Total Problems, Internalizing Problems, and Externalizing Problems) reliable change 
index (RCI) of 4.8 points as indicative of reliable clinical improvement (McClendon et al., 
2011). 
 Revised Child Anxiety and Depression Scale – Youth and Parent Versions 
(RCADS) (Chorpita, Yim, Moffitt, Umemoto, & Francis, 2000). The RCADS is a 47-item 
child self-report measure that assesses symptoms of several DSM-IV-TR anxiety and 
depressive disorders. The measure yields 6 factors (i.e., separation anxiety disorder, social 
phobia, obsessive-compulsive disorder, panic disorder, generalized anxiety disorder, and 
major depressive disorder) and 2 total scores. The RCADS has a strong psychometric profile 
including alphas ranging between .71 and .85 and one-week retest reliability coefficients 
ranging from .65 to .80. In addition, the RCADS depression scale correlated highly (.70) with 
the Children’s Depression Inventory whereas the several anxiety scales were correlated 
highly with the Revised Child Manifest Anxiety Scale (e.g., de Ross, Gullone, & Chorpita, 
2002). There is currently no information in the literature on a specific reliable change index 
for the RCADS. 
 Strengths and Difficulties Questionnaire (SDQ) (Goodman, 2001). The SDQ is a 
brief (25 items) parent report behavioral screening measure that can be used for children ages 
3-17 years of age. Norms for children in the United States were gleaned from the National 
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Health Interview Study, which included a sample of 9,878 children. The SDQ has 5 
subscales (five items per subscale) for internalizing and externalizing behaviors (Emotional 
Distress, Conduct Problems, Hyperactivity, Peer Problems, and Prosocial) and a total Overall 
Stress scale. Overall Stress scale scores on the Symptoms and Difficulties Questionnaire 
(SDQ) from 14 to 16 are considered “borderline” while those scores above 17 are considered 
to indicate “abnormal” levels of overall stress (Goodman, 2001). Retest reliability .62 and 
internal reliability estimates are above .70. Although no reliable change index exists for the 
SDQ, the SDQ has been shown to successfully differentiate between youth who were 
identified as having a disorder with those who were not (Goodman, 2001). 
Functioning domain.  
 Columbia Impairment Scale (CIS) (Bird et al., 1993). This is a 13-item scale 
designed to provide a global measure of psychosocial impairment based on parent report. The 
scale was designed to assess four major areas of functioning: interpersonal relations, certain 
broad areas of psychopathology, functioning at school or work, and use of leisure time. Items 
are scored on a Likert scale ranging from 0 (no problem) to 4 (a very big problem); the 
potential total score ranges 0 to 52. A score of 16 or greater is considered indicative of 
definite impairment (Bird et al., 1993); thus, higher scores indicate greater levels of 
impairment. It has been demonstrated that the CIS provides an adequately reliable and valid 
measure of impairment and also correlates highly with the clinician determined scores of the 
Children’s Global Assessment Scale (Shaffer et al., 1983; Bird et al., 1993). Internal 
consistency reliability ranges from .85 to .89 and test retest reliability (mean =14.7 days) is 
.89. 
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 Brief Impairment Scale (BIS) (Bird et al., 2005). This is a 23-item scale that 
provides a parental report of their child’s functioning across the following domains: 
interpersonal relations, school/work, and self-care/self-fulfillment. A score of 14 or greater is 
considered indicative of definite impairment (Bird et al., 2005); thus higher scores indicate 
greater levels of impairment. The measure has demonstrated high convergent and concurrent 
validity. Internal consistency scores range from .81 to .88 and from .56 to .81 on the three 
subscales and test-retest reliability coefficients around .70. 
Table 2.   
Measurement Battery Composition at Each Assessment Point 
Measures Baseline 
Assessment 1 
(Intake) 
Baseline 
Assessments 2-4 
Treatment 
Assessments 
Follow-up 
Assessments 1-3 
K-SADS Collected   Collected 
CBCL Collected Collected Collected Collected 
RCADS Collected Collected Collected Collected 
SDQ Collected Collected Collected Collected 
CIS Collected Collected Collected Collected 
BIS Collected Collected Collected Collected 
 
Procedures 
 The clinic’s intake manager informed children and families from the clinic’s 
outpatient referral pool, between the ages of 7 and 16, about the study. Interested families 
were asked for permission to provide the researchers with name and telephone only. Virginia 
Commonwealth University research staff screened families for interest and possible fit with 
study inclusion criteria. Children with a primary referral problem related to anxiety and/or 
depression with externalizing symptomatology were invited to an initial intake session. 
Children and families were consented and assented and a battery of tests was administered 
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(see Table 1). If inclusion criteria were met, participants were officially enrolled in the study. 
Participants received a $35 gift card for the first assessment and then a $20 gift card for the 
subsequent assessment meetings. The study is approved by the Virginia Commonwealth 
University (VCU) Institutional Review Board. 
Assessments 
 Single-case research design involves multiple assessments before, during, and after an 
intervention (Kazdin, 1982). In the case of the present study, assessments were conducted 
during a baseline period, during treatment, and after follow up. To determine the length of 
the baseline period for each participant, we employed a randomization procedure. 
Methodologists have recommended this procedure to strengthen single-case design (Koehler 
& Levin, 1998). Randomization will allow for systematic staggered introduction of the 
treatment phase across youths, with the goal of demonstrating effect produced during the 
targeted phase while controlling for other variables (e.g., history) (Koehler & Levin, 1998). 
Therefore, the number of baseline assessments was determined randomly using a random 
number generation program. It has been suggested that in order to stabilize the baseline 
before introduction of the treatment phase a data based baseline determination procedure 
should be used (Koehler & Levin, 1998; Kazdin, 1982). Unfortunately, due to clinic 
regulations, youth could not wait more than a month to begin treatment and therefore we 
could not continue to administer baseline assessment until a stable pattern of outcomes was 
produced. Overall, the study was designed so that each family would receive at least 6 
assessments across the three phases. Assessments were spaced out based on feedback from 
families and therapists about what might work best. 
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Baseline phase. Each participant had between 1 to 5 assessments in the baseline 
phase, including the initial meeting; the number for each family was determined randomly at 
the conclusion of the first assessment. The number of assessments was constrained to be at 
least 3 and no more than 5. The number of baseline assessments was also affected by the 
availability of the families to come into the clinic.  
 Treatment phase. Treatment was limited to 20 sessions based on feedback from 
families and therapists about what might work best. The treatment phase lasted the entire 
course of treatment and assessments occurred every six weeks. Similar to the baseline phase, 
treatment assessments were affected by the availability of the families to come into the clinic. 
This is also true of the follow-up assessments. 
 Follow-up phase. This phase consisted of assessments every eight weeks. All 
families were assessed as soon as possible after the last treatment session, which counted as 
the first follow-up assessment. The total number of follow-up assessments was determined 
by the number of previous assessments in the baseline and treatment phases (1 to 3 total). 
Treatment 
 The treatment used in the study varied by participant and was based on two primary 
treatment manuals: Coping Cat and PASCET. The Coping Cat program is an individual-
based cognitive-behavioral treatment (ICBT) for youth anxiety disorders (Kendall, Kane, 
Howard, & Siqueland, 1990). Coping Cat is a 16- to 20-session manual-based treatment 
program that involves a skills training component and an exposure component. The PASCET 
program (Weisz, Moore, Southam-Gerow, Weersing, Valeri & McCarty, 1999) is a 15-
session, manualized, cognitive-behavioral treatment program focused on treating children 
with depressive disorders (Weisz, Southam-Gerow, Gordis, & Connor-Smith, 2003). The 
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PASCET program centers on helping youth control their mood through strengthening of 
primary and secondary control and coping skills. For cases where conduct problems were 
present and interfering, a parent-training manual was also employed (Barkley, 1997). These 
three manuals were chosen for the study because they have large evidence bases that support 
their use as well-established efficacious treatments for children and adolescents and they 
have also been tested or are being tested in community settings (Weisz et al., 2009). In the 
next section, I will describe the different treatment elements used in the study. 
 Elements. 
 Psychoeducation is a key treatment component where an individual is provided 
information about the nature of their presenting problem or about general psychological 
principles. For this study, psychoeducation was tailored towards a participant’s specific 
diagnostic profile. Emotion education involves identifying individualized somatic reactions 
to distress so that a youth can begin to implement a plan for coping with their problem. 
Exposure is a key component of cognitive-behavioral treatment for anxiety in which repeated 
contact to a stimulus that is feared but safe leads to a reduction or elimination of the fear 
response. A fear ladder, is part of exposure, and helps a youth identify a feared stimulus and 
create a list with an array of ways to expose the youth to the feared stimulus. In cognitive 
restructuring, an individual is taught to identify and challenge distorted or inaccurate 
thinking and then work to develop a more realistic belief system. Self-monitoring helps a 
youth attend to their thoughts, feelings, and behaviors and provides essential feedback about 
the changes that need to be made and how well the process is going. Relaxation strategies 
involve teaching an individual a method for self-calming which may include breathing 
retraining and/or progressive muscle relaxation. Breathing retraining is where youth are 
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taught to breathe more deeply and from his/her diaphragm. Progressive muscle relaxation 
involves teaching youth to tense and relax different muscle groups, which helps a youth to 
recognize bodily tension in their body, and thereby engage in relaxation. With rewards and 
praise, a therapist can directly shape the youth’s behavior to be more adaptive using positive 
reinforcement (i.e., providing a desired consequence when the desired behavior is performed) 
and/or negative reinforcement (i.e., removing or reducing something undesirable such as a 
chore when the desired behavior is performed) and can also teach the youth’s caregiver to 
administer the rewards. Problem solving is where a youth is taught to identify the problem 
and brainstorm all possible options on how to solve it. Once this has been accomplished, the 
next step is to evaluate all positive and negative consequences for each option as well as the 
advantages and disadvantages, and try out an option. Primary control and secondary control 
coping are two complementary ways of handling stressful situations. Primary control coping 
involves actions taken to change the situation and secondary control coping involves actions 
taken to change the way an individual views the situation. Activity selection helps youth to 
learn to increase age-appropriate pleasant activities by identifying pleasant activities and 
arranging their schedule to increase their frequency. Social skills (e.g., learning to start a 
conversation, listening actively) help youth who are having difficulty making and retaining 
friendships. Time out and active ignoring are two treatment elements that are commonly used 
in children with externalizing symptoms. When an undesirable behavior occurs, time out 
removes the youth from a desirable activity and the youth must be placed in a location that is 
free from reinforcement, in order to reduce the behavior. Active ignoring teaches caregivers 
to ignore unwanted behavior and only pay attention to wanted behavior. One on one time and 
communication skills training are used to improve the relationship between the youth and 
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his/her caregiver(s) by increasing time spent together in pleasurable activities, as well as 
allowing youth and his/her caregiver(s) to practice different ways of talking with each other 
about challenging situations. 
Order of elements from the treatment manuals did not follow the manuals but instead 
was determined during supervision based on input from the therapist and the supervisor, 
following the partnership model of shared responsibility for study procedures. Earlier 
treatment choices were made by both the therapist and supervisor based on a participant’s 
case conceptualization. Decisions were then made during supervision based on the 
participant’s progression through treatment and how well the participant was responding to 
certain treatment elements. Treatment shifted in the case of a change in the therapist’s case 
conceptualization of the participant or if a new issue arose from previous therapy sessions.  
In addition to elements from the three manuals, other procedures were introduced and used 
based on input from the therapists and drawing on the supervisor’s knowledge of the 
evidence base (e.g., communication skills training). In all cases, elements added to a 
treatment plan were drawn from treatment programs with empirical support. All treatment 
plans were documented and are described below. 
 Participant 1 was lost to follow-up so no treatment plan will be reported. 
Participant 2’s treatment focused on anxiety symptoms and consisted of (a) psycho-
education for child and parent, (b) emotion education, (c) relaxation, (d) fear ladder, (e) 
cognitive, (f) problem solving, and (g) exposure. 
 Participant 3’s treatment focused on both depression and conduct symptoms and 
consisted of (a) psycho-education for both the parent and child on depression, (b) activity 
selection, (c) one on one time, (d) social skills, (e) rewards, (f) psycho-education on conduct 
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and ADHD for both child and parent, (g) cognitive, (h) three step plan (i.e., sequential coping 
from PASCET), and (i) maintenance. 
 Participant 4’s treatment focused on anxiety symptoms and consisted of (a) psycho-
education for child and parent, (b) monitoring of anxiety symptoms, (c) hyperventilation, (d) 
breathing retraining, (e) cognitive, (f) relaxation, (g) interoceptive exposure, (h) fear ladder, 
and (i) exposure. 
 Participant 5’s treatment focused on depression symptoms and consisted of (a) 
psycho-education for child and parent, (b) activity selection, (c) cognitive, and (d) problem 
solving. 
 Participant 6’s treatment focused on both depression and conduct symptoms and 
consisted of (a) psycho-education for child and parent on ADHD, (b) praise, (c) one on one 
time, (d) active ignoring, (e) cognitive, (f) problem solving, (g) rewards, (h) time out, and (i) 
antecedent management/stimulus control. 
Participant 7’s treatment focused on anxiety symptoms. Participant 7 did not get very 
far in treatment and only had two intake sessions with the therapist before stopping therapy. 
Participant 8’s treatment focused on depression symptoms and consisted of (a) 
psycho-education for child and parent, (b) activity selection, (c) relaxation, and (d) 
communication skills training. 
Therapists 
 Therapists were two full-time masters level clinicians employed by the clinic. 
Therapist A was a female therapist at the clinic with a Master’s degree in social work. She 
treated participants 3, 6, and, 7. Therapist B was a male therapist at the clinic with Master’s 
degree in clinical psychology. He treated participants 2, 4, 5, and 8. Therapists were trained 
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and supervised by Michael Southam-Gerow, Ph.D., study PI. Training took place over a 2-
day period at Virginia Commonwealth University. Therapists completed a consent procedure. 
Supervision consisted group meetings and included weekly tape review. 
Analytic Plan 
 The study will use two methods of analyses: (a) Visual Analyses and (b) Clinical 
Significance Analyses. Each case will involve analyses for the measures relevant to the 
presenting symptoms, similar to what Kazdin refers to as “response-specific” measures 
because the selection of measures to be analyzed for each participant is matched to their 
particular target problems (1982). Visual analyses will involve graphing participants’ scores 
on the multiple measures for child and parent reports, examining changes in mean and 
changes in trend across assessment phases for improvement in symptoms, and determining 
whether any changes are related to treatment. Clinical significance analyses (Kendall, 
Flannery-Schroeder, & Ford, 1999) will be employed for measures possessing normative 
ranges (i.e. K-SADS, CBCL, and RCADS). Participants will be classified as treatment 
success/failure based on their status on these measures, as compared to normative ranges, at 
the follow-up assessment points. 
Results 
Overview 
 In the following section, each participant’s data will be presented in graph form for 
all completed baseline, treatment, and follow-up assessments. For each participant I will first 
report outcomes for the symptoms and diagnosis domain followed by functioning domain 
outcomes. The completed battery evolved over time and thus each participant had a 
somewhat different set of measures. Further, given the focus of treatment differed by 
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participant, outcomes for each participant were judged using measures that best indexed the 
participant’s primary focus of treatment. Table 3 summarizes the measurement data that will 
be presented for each participant. 
Table 3.   
Treatment Outcome Measures for Each Participant. 
Participant 
Number 
 
Primary Focus 
of Treatment 
 
Symptoms and Diagnosis Outcome 
Measures 
 
Functioning Outcome 
Measures 
 
1 Depression and 
Externalizing 
Symptoms 
Lost to follow-up. No treatment outcomes 
will be reported. 
Lost to follow-up. No 
treatment outcomes 
will be reported. 
2 
 
Anxiety 
 
1. RCADS Total Anxiety T-score; 2. 
CBCL Internalizing Problems and Anxiety 
Symptoms T-scores; 3. K-SADS-PL 
diagnosis 
1. CIS Total Score 
3 Depression and 
Externalizing 
Symptoms 
 
1. RCADS Total Depression T-score; 2. 
CBCL Internalizing Problems and 
Externalizing Problems T-scores; 3. K-
SADS-PL diagnosis 
1. CIS Total Score  
4 
 
Anxiety 
 
1. RCADS Total Anxiety T-score; 2. 
CBCL Internalizing Problems and Anxiety 
Symptoms T-scores; 3. SDQ Overall 
Stress total scale score; 4. K-SADS-PL 
diagnosis 
1. CIS Total Score  
5 
 
Depression 
 
1. RCADS Total Depression T-score; 2. 
SDQ Overall Stress total scale score; 3. K-
SADS-PL diagnosis 
1. BIS Total Score 
6 
 
Depression and 
Externalizing 
Symptoms 
 
1. RCADS Total Depression T-score; 2. 
SDQ Overall Stress total scale score; 3. K-
SADS-PL diagnosis 
1. BIS Total Score 
 
7 
 
Anxiety 
 
1. RCADS Total Anxiety T-score; 2. SDQ 
Overall Stress total scale score; 3. K-
SADS-PL diagnosis 
1. BIS Total Score 
 
8 Depression 1. RCADS Total Depression T-score; 2. 
SDQ Overall Stress total scale score; 3. K-
SADS-PL diagnosis 
1. BIS Total Score 
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  T-scores above 65 on the Revised Child Anxiety and Depression Scale (RCADS) are 
considered indicative of “clinically significant” symptoms (Chorpita et al., 2000). T-scores 
above 60 on the Child Behavior Checklist (CBCL) Internalizing and Externalizing Problems 
scale are considered to indicate clinical significance, whereas T-scores above 65 on the Child 
Behavior Checklist (CBCL) Anxiety Syndrome scale are considered to indicate clinical 
significance (Achenbach & Rescorla, 2001). The RCI of 4.8 points will also be used to 
indicate clinically significant change on the CBCL Internalizing and Externalizing Problems 
scale (McClendon et al., 2011). Overall Stress scale scores on the Symptoms and Difficulties 
Questionnaire (SDQ) from 14 to 16 are considered “borderline” while those scores above 17 
are considered to indicate “abnormal” levels of overall stress (Goodman, 2001). For the 
functioning domain, a score of 16 or greater on the CIS is considered indicative of definite 
impairment, while a score of 14 or greater on the BIS is considered indicative of definite 
impairment (Bird et al., 1993). 
 Both the symptoms and diagnosis outcome measures and the functioning outcome 
measures graphs will contain constant elements to assist in visual and clinical significance 
analyses. For measures with a clinical cutoff score (i.e., RCADS, CBCL, SDQ), the clinical 
cutoff will be graphed for each assessment point in order to visually indicate when a 
participant’s scores have fallen below or above this line. For all measures, the mean phase 
scores will be graphed in order to indicate a change in mean level for each assessment phase. 
The graphs will also contain a linear trend line in order to indicate whether a change in trend 
has occurred throughout the assessment phases. 
Participant 1 
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 As stated previously, Participant 1 was lost to follow-up. Due to a lack of data for 
comparison across phases, this participant was excluded from analysis.  
Participant 2 
 Symptoms and diagnosis domain. 
 Child report measure. Participant 2 completed eight total assessments (3 baseline, 3 
treatment, and 2 follow-up).  The results of Participant 2’s self-reported levels of anxiety 
using the Total Anxiety scale of the Revised Child Anxiety and Depression Scale (RCADS) 
are presented in Figure 1. These results indicate that Participant 2 experienced his highest 
level of anxiety (T-score = 50) at the first baseline assessment. Participant 2’s Total Anxiety 
T-scores mean for each assessment phase declined over baseline (mean T-score = 45), 
treatment (mean T-score = 38.3), and follow-up (mean T-score = 32.6). The results also 
indicate a linear trend towards decreasing anxiety symptoms from baseline to follow-up.  
 
Figure 1. RCADS T-scores across baseline, treatment, and follow-up for participant 2. 
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While Participant 2’s results show a general reduction in Total Anxiety T-scores from 
baseline to treatment and treatment to follow-up, he never demonstrated T-scores in the 
clinically significant range.  
 Parent report measures. The results of Participant 2’s parent report of internalizing 
behavior problems on the Child Behavior Checklist (CBCL) Internalizing Problems scale are 
displayed in Figure 2. Parental report reveals a linear trend of consistent decline in T-scores 
throughout the assessment phases. Though results indicate a relatively stable but declining 
trend from the first baseline to the first treatment assessment, these reports indicate an 
increase in internalizing behaviors at the second treatment assessment (T-score = 63).  
 
Figure 2. CBCL Internalizing T-scores across baseline, treatment, and follow-up for 
participant 2. 
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Participant 2’s Internalizing Problems T-scores mean for each assessment phase declined 
over baseline (mean T-score = 60.5), treatment (mean T-score = 56.6), and follow-up (mean 
T-score = 47). These results reveal a visually significant decrease in parental report of 
internalizing behavior from baseline to follow-up. These results also meet criteria for reliable 
change with a reduction of 13.5 points from baseline mean score to follow-up mean score. 
Further, reports of internalizing behaviors in the clinically significant range at baseline were 
no longer significant by the final follow-up. So, these findings indicate that according to 
scores on the CBCL Internalizing scale, Participant 2 can be categorized as recovered. 
 The results of Participant 2’s parent report of anxiety symptoms on the Child 
Behavior Checklist (CBCL) Anxiety syndrome scale are displayed in Figure 3. Parental 
report reveals a linear trend of a decrease in T-scores throughout the assessment phases. 
Though results indicate a relatively stable but declining trend from the first baseline to the 
first treatment assessment, these reports indicate an increase in anxiety at the second 
treatment assessment (T-score = 70). Participant 2’s Anxiety syndrome scale T-scores mean 
for each assessment phase declined over baseline (mean T-score = 71.5), treatment (mean T-
score = 66), and follow-up (mean T-score = 58).  
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Figure 3. CBCL Anxiety T-scores across baseline, treatment, and follow-up for participant 2. 
These results reveal a visually significant decrease in parental report of anxiety from baseline 
to follow-up. Further, reports of anxiety in the clinically significant range at baseline were no 
longer significant by the final follow-up.  
The initial diagnostic interview using the parent report version of the K-SADS-PL 
indicated that Participant 2’s behavior reached criteria for Social Phobia. This was the only 
disorder for which his behaviors reached diagnostic criteria at the initial baseline assessment. 
Results indicate that Participant 2 did not reach diagnostic criteria for Social Phobia or for 
any other DSM-IV disorder at any point during the follow-up assessments. 
 Functioning Domain. 
 Parent report measure. The results of Participant 2’s parent report of functional 
impairment on the Columbia Impairment Scale (CIS) and represented as total scale scores are 
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displayed in Figure 4. Results indicate a declining trend from the first baseline assessment to 
the last follow-up assessment. Participant 2’s CIS total scale scores mean for each assessment 
phase declined over baseline (mean scale score = 11.6), treatment (mean scale score = 8), and 
follow-up (mean scale score = 2.5). Further, these results reveal a visually significant 
decrease in parental report of functional impairment from baseline to follow-up. 
 
Figure 4. CIS total scale scores across baseline, treatment, and follow-up for participant 2. 
 Overall, Participant 2 is a treatment success. For child-reported symptoms for the 
RCADS, although participant 2 was never “clinically significant” his anxiety symptoms 
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indicated reliable change based on the RCI.  This indicates that Participant 2 can be classified 
as recovered, both passing clinical cutoff and meeting RCI criteria. 
 Results also demonstrate that Participant 2 no longer met diagnostic criteria for any DSM-IV 
disorder at follow-up. Parent-reported functioning also indicated a decline in functional 
impairment from baseline to follow-up. 
Participant 3 
 Symptoms and diagnosis domain. 
 Child report measure. Participant 3 completed twelve total assessments (5 baseline, 5 
treatment, and 2 follow-up).  The results of Participant 3’s self-reported levels of depression 
using the Total Depression scale of the Revised Child Anxiety and Depression Scale 
(RCADS) and represented as overall T-scores are presented in Figure 5. These results 
indicate that Participant 3 experienced his highest level of depression (T-score = 50) at the 
first baseline assessment, and that his depression during treatment and follow-up phases 
remained consistently between T-scores of 36 and 55. 
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Figure 5. RCADS T-scores across baseline, treatment, and follow-up for participant 3. 
 
 Participant 3’s Total Depression T-scores declined over baseline and remained relatively 
stable over treatment and follow-up. Participant 3’s Total Depression T-scores mean for each 
assessment phase also remained relatively stable during baseline (mean T-score = 47), 
treatment (mean T-score = 44.4), and follow-up (mean T-score = 46). The results also 
indicate a minimal downward linear trend in depression symptoms from baseline to follow-
up. RCADS T-scores above 65 are considered indicative of “clinically significant” symptoms 
(Chorpita et al., 2000). While Participant 3 showed minimal mean change in Total 
Depression, he never demonstrated T-scores in the clinically significant range.  
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Figure 6. CBCL Total Internalizing T-scores across baseline, treatment, and follow-up for 
participant 3. 
 Parent report measures. The results of Participant 3’s parent report of internalizing 
behavior problems on the Child Behavior Checklist (CBCL) Internalizing Problems scale and 
represented as T-scores are displayed in Figure 6. Parental report reveals a relatively stable 
but slight decline of linear trend in T-scores throughout the assessment phases. Though these 
results reveal minimal change in T-score means from baseline (mean T-score = 74) to 
treatment (mean T-score = 73.5), these results indicate a decrease in the mean Internalizing 
T-score at follow-up (mean T-score = 68).  T-scores above 60 on the CBCL Internalizing 
Problems scale are considered to indicate clinical significance (Achenbach & Rescorla, 
2001). Although these results reveal a slight decline in parental report of internalizing 
behavior from baseline to follow-up and meet criteria for reliable change with a decrease of 6 
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points from baseline to follow-up, parental report indicates that Participant 3’s internalizing 
behavior problems are still clinically significant. This suggests that Participant 3’s scores are 
improved but not recovered, because although he passed RCI criteria, he did not pass the 
clinical cutoff. 
 
Figure 7. CBCL Externalizing T-scores across baseline, treatment, and follow-up for 
participant 3. 
 The results of Participant 3’s parent report of externalizing behavior problems on the 
Child Behavior Checklist (CBCL) Externalizing Problems scale and represented as T-scores 
are displayed in Figure 7. Parental report indicates that Participant 3 experienced his highest 
level of externalizing behavior at the first baseline assessment (T-score = 82).  These results 
reveal a relatively stable decline in linear trend of T-scores throughout the assessment phases. 
Parental report indicates a decrease in T-score means from baseline (mean T-score = 79), 
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treatment (mean T-score = 71.75), and follow-up (mean T-score = 72).  T-scores above 60 on 
the CBCL Externalizing Problems scale are considered to indicate clinical significance 
(Achenbach & Rescorla, 2001). Although these results reveal a visually significant decrease 
in parental report of externalizing behavior from baseline to follow-up and meet criteria for 
reliable change with a decrease of 8 points from baseline to follow-up, parental report 
indicates that Participant 3’s externalizing behavior problems are still in the clinically 
significant range. This suggests that although Participant 3 met RCI criteria, he can only be 
categorized as improved because his scores do not fall below the clinical cutoff point. 
 The initial diagnostic interview using the parent report version of the K-SADS-PL 
indicated that Participant 3’s behavior reached criteria for Minor Depression, ADHD, and 
ODD. These were the only disorders for which his behaviors reached diagnostic criteria at 
the initial baseline assessment. Results indicate that Participant 3 did not meet criteria for 
Minor Depression and ODD at both follow-up assessments. Participant 3 however, still met 
diagnostic criteria for ADHD at both follow-up assessments. 
 Functioning Domain. 
 Parent report measure. The results of Participant 3’s parent report of functional 
impairment on the Columbia Impairment Scale (CIS) and represented as total scale scores are 
displayed in Figure 8. The results demonstrate that Participant 3’s CIS total scale scores 
remained relatively stable during the baseline phase (scale scores ranging from 40 to 35) with 
a mean scale score of 38.4, and then decreased with slight variability across treatment (mean 
scale score = 28.5). During the follow-up phase, Participant 3’s scale scores increased to a 
mean scale score of 35.5. Further, these results reveal a slight linear decrease in parental 
report of functional impairment from baseline to follow-up. 
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Figure 8. CIS total scale scores across baseline, treatment, and follow-up for participant 3. 
 Overall, Participant 3 has poor outcomes, suggesting treatment was not successful. 
For child-reported symptoms for the RCADS, although participant 3 was never “clinically 
significant” his anxiety symptoms only decreased slightly from baseline to follow-up. Both 
parent-reported CBCL scales that were “clinically significant” at baseline remained 
“clinically significant” at follow-up. Results also demonstrate that Participant 3 still met 
criteria for ADHD at follow-up, but did not meet criteria for his other two baseline diagnoses 
(minor depression, ODD). Parent-reported functioning only indicated a minimal decline in 
functional impairment from baseline to follow-up. Participant 3’s mean score on the BIS at 
follow-up (35.5) indicated definite impairment. 
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 Child report measure. Participant 4 completed eight total assessments (3 baseline, 2 
treatment, and 3 follow-up).  The results of Participant 4’s self-reported levels of anxiety 
using the Total Anxiety scale of the Revised Child Anxiety and Depression Scale (RCADS) 
and represented as overall T-scores are presented in Figure 9. These results indicate that 
Participant 4 experienced his highest level of anxiety (T-score = 66) at the first baseline 
assessment. Participant 4’s Total Anxiety T-scores mean for each assessment phase declined 
over baseline (mean T-score = 63.3), treatment (mean T-score = 55), and follow-up (mean T-
score = 33.3).  
 
Figure 9. RCADS Total Anxiety T-Scores across baseline, treatment, and follow-up for 
participant 4. 
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considered indicative of “clinically significant” symptoms (Chorpita et al., 2000). Participant 
4’s Anxiety T-scores were within the range of clinical significance in the first (T-score = 66) 
and second baseline (T-score = 65) assessment and were below the level of clinical 
significance for the last baseline assessment. Participant 4’s Anxiety T-scores remained 
below the clinical range throughout treatment and follow-up assessments. 
 
Figure 10. CBCL Internalizing T-scores across baseline, treatment, and follow-up for 
participant 4. 
 Parent report measures. The results of Participant 4’s parent report of internalizing 
behavior problems on the Child Behavior Checklist (CBCL) Internalizing Problems scale and 
represented as T-scores are displayed in Figure 10. The results demonstrate that parental 
report of Participant 4’s internalizing behavior problems remained relatively stable during the 
baseline phase (T-scores ranging from 65 to 62), and then decreased with slight variability 
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across treatment and follow-up. The results of the CBCL Internalizing T-scores graph 
indicates that Participant 4 received scores in the range of clinical significance during 
baseline, but by the first treatment assessment his scores had fallen below a clinical level (T-
score = 57). Participant 4’s Internalizing Problems T-scores mean for each assessment phase 
declined over baseline (mean T-score = 63.5), treatment (mean T-score = 54.5), and follow-
up (mean T-score = 44.6), indicating reliable change with a decrease of 18.9 points from 
baseline to follow-up.  This indicates that Participant 4 can be categorized as recovered due 
to both meeting RCI criteria and no longer being above the clinical cutoff. T-scores above 60 
on the CBCL Internalizing Problems scale are considered to indicate clinical significance 
(Achenbach & Rescorla, 2001). These results reveal a visually significant linear decrease in 
parental report of internalizing behavior from baseline to follow-up. Further, reports of 
internalizing behaviors in the clinically significant range at baseline were no longer 
significant by the final follow-up. 
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Figure 11. CBCL Anxiety T-scores across baseline, treatment, and follow-up for participant 
4. 
 The results of Participant 4’s parent report of anxiety symptoms on the Child 
Behavior Checklist (CBCL) Anxiety syndrome scale and represented as T-scores are 
displayed in Figure 11. The results demonstrate that parental report of Participant 4’s anxiety 
problems remained relatively stable during the baseline phase (T-scores ranging from 71 to 
70), and then decreased with slight variability across treatment and follow-up. The results of 
the CBCL Anxiety T-scores graph indicates that Participant 4 received scores in the range of 
clinical significance during baseline, but by the second treatment assessment his scores had 
fallen below a clinical level (T-score = 62). Participant 4’s Anxiety T-scores mean for each 
assessment phase declined over baseline (mean T-score = 70.5), treatment (mean T-score = 
64), and follow-up (mean T-score = 53.6).  T-scores above 65 on the CBCL Anxiety 
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syndrome scale are considered to indicate clinical significance (Achenbach & Rescorla, 
2001). These results reveal a visually significant decrease in parental report of anxiety from 
baseline to follow-up. Further, reports of anxiety in the clinically significant range at baseline 
were no longer significant by the final follow-up. 
 The results of Participant 4’s parent report of levels of overall stress using the 
Symptoms and Difficulties Questionnaire (SDQ) and represented as overall scale scores are 
presented in Figure 12. The results indicate that Participant 4’s SDQ scores decreased from a 
mean score of 12.3 at baseline down to 8.5 at treatment, and declined to a 6 at the last two 
follow-up assessments. The results of Participant 4’s parental reports of Overall Stress scores 
graph indicates that he received a score in the borderline range in the second baseline 
assessment (score = 15), but by the third baseline assessment his scores had fallen into the 
normal range of scores. These results reveal a visually significant decrease in parental report 
of overall stress from baseline to follow-up. 
The initial diagnostic interview using the parent report version of the K-SADS-PL 
indicated that Participant 4’s behavior reached criteria for Panic Disorder and Separation 
Anxiety Disorder. These were the only disorders for which his behaviors reached diagnostic 
criteria at the initial baseline assessment. Results indicate that Participant 4 did not reach 
diagnostic criteria for Panic Disorder or Separation Anxiety Disorder, or for any other DSM-
IV disorder at any point during the follow-up assessments. 
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Figure 12. SDQ Overall Stress scores across baseline, treatment, and follow-up for 
participant 4. 
 Functioning Domain. 
 Parent report measure. The results of Participant 4’s parent report of functional 
impairment on the Columbia Impairment Scale (CIS) and represented as total scale scores are 
displayed in Figure 13. The results demonstrate that Participant 4’s CIS total scale scores 
remained relatively stable during the baseline phase (scale scores ranging from 18 to 16), and 
then sharply decreased to 9 at the first treatment assessment to a low of 2 at the second 
follow-up assessment, before increasing slightly to 7 at the final follow-up.  Participant 4’s 
CIS total scale scores mean for each assessment phase decreased sharply from baseline 
(mean scale score = 17 to treatment (mean scale score = 6.5), and then decreased slightly 
from treatment to follow-up (mean scale score = 4.3). Further, these results reveal a visually 
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significant linear decrease in parental report of functional impairment from baseline to 
follow-up. 
 
Figure 13. CIS total scale scores across baseline, treatment, and follow-up for participant 4. 
Overall, Participant 4 is a treatment success. For child-reported anxiety symptoms on 
the RCADS, participant 4 was “clinically significant” at baseline and fell below the clinical 
cutoff at follow-up. Both parent-reported CBCL scales that were “clinically significant” at 
baseline were no longer “clinically significant” at follow-up. In addition, the CBCL 
Internalizing scale score decrease of 18.9 points from baseline to follow-up was indicative of 
reliable change. This indicates that, according to Participant 4’s CBCL scores, he can be 
categorized as recovered. Parent reported Overall Stress on the SDQ decreased from 
borderline at baseline to normal at follow-up. Results also demonstrate that Participant 4 no 
longer met diagnostic criteria for any DSM-IV disorder at follow-up. Parent-reported 
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functioning also indicated a decline in functional impairment from baseline to follow-up no 
longer indicating definite impairment. 
Participant 5 
 Symptoms and Diagnosis domain. 
 Child report measure. Participant 5 completed nine total assessments (4 baseline, 2 
treatment, and 3 follow-up).  The results of Participant 5’s self-reported levels of depression 
using the Total Depression scale of the Revised Child Anxiety and Depression Scale 
(RCADS) and represented as overall T-scores are presented in Figure 14. These results 
indicate that Participant 5 experienced his highest level of depression (T-score = 65) at the 
fourth baseline assessment. Participant 5’s Total Depression T-scores mean for each 
assessment phase declined over baseline (mean T-score = 62), treatment (mean T-score = 54), 
and follow-up (mean T-score = 47.3). The results also indicate a visually significant linear 
trend of decreasing depression symptoms from the first baseline assessment to the last 
follow-up. Participant 5’s Depression T-scores were within the range of clinical significance 
in the fourth baseline (T-score = 65). Results indicate Depression T-scores remained below 
the clinical range throughout treatment and follow-up assessments. 
 57 
 
Figure 14. RCADS Depression T-scores across baseline, treatment, and follow-up for 
participant 5. 
 Parent report measures. The results of Participant 5’s parent report of levels of 
overall stress using the Symptoms and Difficulties Questionnaire (SDQ) and represented as 
overall scale scores are presented in Figure 15. The results indicate that Participant 5’s SDQ 
scores decreased from a mean score of 15.5 at baseline down to 14 at treatment, and declined 
to a 9.6 at the last three follow-up assessments. Participant 5’s parental reports of Overall 
Stress scores graph indicates that her first baseline assessment Overall Stress score is in the 
borderline range (score = 16) and her Overall Stress score at the second baseline assessment 
is in the abnormal range of scores (score = 18). Results indicate that scores continued to 
decline the third and fourth baseline assessments as well as the first treatment assessment, 
before increasing into the abnormal range again (score = 18). Participant 5’s Overall Stress 
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scores remained in the normal range of scores throughout follow-up. These results reveal a 
visually significant decrease in parental report of overall stress from baseline to follow-up. 
 
Figure 15. SDQ Overall Stress scores across baseline, treatment, and follow-up for 
participant 5. 
 The initial diagnostic interview using the parent report version of the K-SADS-PL 
indicated that Participant 5’s behavior reached criteria for Minor Depression. This was the 
only disorder for which her behaviors reached diagnostic criteria at the initial baseline 
assessment. Results indicate that Participant 5 did not reach diagnostic criteria for Major 
Depression, or for any other DSM-IV disorder at any point during the follow-up assessments. 
 Functioning Domain. 
  
 Parent report measure. The results of Participant 5’s parent report of functional 
impairment on the Brief Impairment Scale (BIS) and represented as scale scores are 
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displayed in Figure 16. The results demonstrate that Participant 5’s BIS total scale scores 
remained relatively stable during the baseline phase (scale scores ranging from 19 to 14) and 
the treatment phase (18 to 13), and then decreased to 9 at the first follow-up assessment 
before increasing to 12 at the final follow-up. Parental report indicated that the CIS total 
scale score mean decreased from baseline (mean scale score = 17), to treatment (mean scale 
score = 15.5), and to follow-up (mean scale score = 12.3). Further, these results reveal a 
visually significant linear decrease in parental report of functional impairment from baseline 
to follow-up. 
 
Figure 16. BIS total scale scores across baseline, treatment, and follow-up for participant 5. 
Overall, Participant 5 is a treatment success. For child-reported depression symptoms 
on the RCADS, participant 5 was “clinically significant” at baseline and fell below the 
clinical cutoff at follow-up. Parent reported Overall Stress on the SDQ decreased from 
abnormal scores at baseline to normal scores at follow-up. Results also demonstrate that 
19 
18 
14 
17 
13 
18 
16 
9 
12 
17 15.5 
12.3 
4 
6 
8 
10 
12 
14 
16 
18 
20 
B1 B2 B3 B4 T1 T2 F1 F2 F3 
B
IS
 T
ot
al
 S
ca
le
 S
co
re
 
Time of Assessment 
BIS Mean Phase Score BIS Linear Trend 
 60 
Participant 5 no longer met diagnostic criteria for any DSM-IV disorder at follow-up. Parent-
reported functioning also indicated a decline in functional impairment from baseline to 
follow-up no longer indicating definite impairment. 
Participant 6 
 Symptoms and diagnosis domain. 
 Child report measure. Participant 6 completed nine total assessments (3 baseline, 3 
treatment, and 3 follow-up).  The results of Participant 6’s self-reported levels of depression 
using the Total Depression scale of the Revised Child Anxiety and Depression Scale 
(RCADS) and represented as overall T-scores are presented in Figure 17. These results 
indicate that Participant 6 experienced his highest level of depression (T-score = 64) at the 
first baseline assessment. Participant 6’s Total Depression T-scores mean for each assessment 
phase declined over baseline (mean T-score = 58.3), treatment (mean T-score = 43.6), and 
follow-up (mean T-score = 36).  
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Figure 17. RCADS Depression T-scores across baseline, treatment, and follow-up for 
participant 6. 
The results also indicate a visually significant stable, linear trend of decreasing depression 
symptoms from the first baseline assessment to the last follow-up. Results indicate 
Participant 5’s Depression T-scores remained below the clinical range throughout baseline, 
treatment, and follow-up assessments. 
 
 
 
 
 
 
64 
53 
58 
53 
42 
36 
33 
36 
42 
58.3 
43.6 37 
65 
10 
20 
30 
40 
50 
60 
70 
B1 B2 B3 T1 T2 T3 F1 F2 F3 
R
C
A
D
S 
D
ep
re
ss
io
n 
T-
Sc
or
e 
Time of Assessment 
RCADS Depression T score Mean Phase Score 
Clinical Cutoff RCADS Depression Linear Trend 
 62 
  
Figure 18. SDQ Overall Stress scores across baseline, treatment, and follow-up for 
participant 6. 
 Parent report measures. The results of Participant 6’s parent report of levels of 
overall stress using the Symptoms and Difficulties Questionnaire (SDQ) and represented as 
scale scores are presented in Figure 18. The results indicate that Participant 6’s SDQ scale 
scores decreased from a mean score of 20.6 at baseline down to 17.3 at treatment, and 
declined to a mean of 11 for the follow-up phase. Participant 6’s parental reports of Overall 
Stress indicate her scores were in the abnormal range through the baseline phase (24 to 18) 
and the first treatment assessment (22). Her Overall Stress scores then decreased into the 
borderline range for the final two treatment assessments, both a score of 15. Participant 6’s 
scores decreased to a low of 7 for the first follow-up assessment, increased to 16 for the 
second follow-up assessment, and then decreased to 10, into the normal range of scores. 
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These results reveal a visually significant decrease in parental report of overall stress from 
baseline to follow-up. Parent reported overall stress scores were in the normal range at the 
final follow-up. 
The initial diagnostic interview using the parent report version of the K-SADS-PL 
indicated that Participant 6’s behavior reached criteria for minor depression, Enuresis, and 
ADHD. These were the only disorder for which her behaviors reached diagnostic criteria at 
the initial baseline assessment. Results indicate that Participant 6 did not reach diagnostic 
criteria for minor depression or Enuresis at the first follow-up assessment, but did meet 
diagnostic criteria for ADHD. At the third follow-up, Participant 6 met diagnostic criteria for 
ADHD and Enuresis, but did not meet diagnostic criteria for minor depression.  
 Functioning Domain. 
  
 Parent report measure. The results of Participant 6’s parental report of functional 
impairment on the Brief Impairment Scale (BIS) and represented as scale scores are 
displayed in Figure 19. The results demonstrate that Participant 6’s BIS total scale scores 
remained relatively stable during the baseline phase (scale scores ranging from 31 to 25) with 
a mean scale score of 27.3, and the first treatment assessment (28), and then began to decline 
from the second treatment assessment (treatment mean scale score = 19.6) to the first follow-
up assessment (11). Parental report indicated an increase in BIS total scores at the second 
follow-up (scale score = 21) before declining in the final follow-up (follow-up mean scale 
score = 14.3). Further, these results reveal a visually significant linear decrease in parental 
report of functional impairment from baseline to follow-up. 
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 Figure 19. BIS total scale scores across baseline, treatment, and follow-up for participant 6. 
Overall, Participant 6’s treatment outcomes are mixed. For child-reported depression 
symptoms on the RCADS, participant 6 was “clinically significant” at baseline and fell 
below the clinical cutoff at follow-up. Parent reported Overall Stress on the SDQ decreased 
from abnormal scores at baseline to normal scores at follow-up. Participant 6 did meet 
diagnostic criteria for ADHD and enuresis at follow-up, although he no longer met criteria 
for minor depression. Parent-reported functioning also indicated a decline in functional 
impairment from baseline to follow-up, although the BIS mean score (14.3) at follow up still 
indicated definite impairment. 
Participant 7 
 Symptoms and diagnosis domain. 
 Child report measure. Participant 7 completed eight total assessments (3 baseline, 1 
treatment, and 4 follow-up).  The results of Participant 7’s self-reported levels of anxiety 
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using the Total Anxiety scale of the Revised Child Anxiety and Depression Scale (RCADS) 
and represented as overall T-scores are presented in Figure 20. These results indicate that 
Participant 7 experienced her highest level of anxiety (T-score = 62) at the last follow-up 
assessment. Participant 7’s Total Anxiety T-scores mean for each assessment phase increased 
over baseline (mean T-score = 47.6), treatment (mean T-score = 48), and follow-up (mean T-
score = 51). The results also indicate a linear trend towards increasing anxiety symptoms 
from baseline to follow-up.  
 
Figure 20. RCADS T-scores across baseline, treatment, and follow-up for participant 7. 
While Participant 7’s results show a general increase in Total Anxiety T-scores from baseline 
to treatment and treatment to follow-up, Participant 7’s Anxiety T-scores never reach 
clinically significant levels. 
 Parent report measures. The results of Participant 7’s scores of overall stress using 
the Symptoms and Difficulties Questionnaire (SDQ) parent-report and represented as overall 
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scale scores are presented in Figure 21. The results indicate that Participant 7’s SDQ scores 
remained relatively stable during baseline and treatment phase. At the second follow-up the 
Overall Stress score increased to 17 and then decreased to 9 at the third follow-up before 
increasing again to 15. The results of Participant 7’s parental reports graph indicates Overall 
Stress scores were in the borderline range from the first baseline assessment to the first 
follow-up assessment and increased to the abnormal range at the second follow-up. 
Participant 7’s Overall Scores were in a normal range at the third follow-up assessment and 
returned to the borderline range in the final follow-up. These results reveal a slight 
downward trend in parental report of overall stress from baseline to follow-up.  
  
Figure 21. SDQ Overall Stress scores across baseline, treatment, and follow-up for 
participant 7. 
16 16 
15 
16 
15 
17 
9 
15 15.6 14 
14 
17 
5 
7 
9 
11 
13 
15 
17 
19 
B1 B2 B3 T1 F1 F2 F3 F4 
SD
Q
 O
ve
ra
ll 
St
re
ss
 S
co
re
 
Time of Assessment 
SDQ Overall Stress Mean Phase Score 
Borderline Abnormal 
 67 
The initial diagnostic interview using the parent report version of the K-SADS-PL 
indicated that Participant 7’s behavior reached DSM-IV criteria for Simple Phobia, Social 
Phobia, and Generalized Anxiety Disorder. Results indicate that Participant 7 only met 
criteria for Simple Phobia and Social Phobia at the first follow-up assessment. The diagnostic 
interview at the second follow-up assessment indicated that Participant 7 only met criteria for 
Simple Phobia and at the final follow-up assessment Participant 7 met criteria for Simple 
Phobia and Social Phobia. 
Functioning Domain. 
 
Parent report measure. The results of Participant 7’s parent report of functional 
impairment on the Brief Impairment Scale (BIS) and represented as scale scores are 
displayed in Figure 22. The results demonstrate that Participant 7’s BIS total scale scores 
declined from the first baseline to the final follow-up assessment. Parental report indicates a 
decrease in the BIS total scores mean from baseline (mean scale score = 12.6) to follow-up 
(mean scale score = 9.25). Further, these results reveal a visually significant linear decrease 
in parental report of functional impairment from baseline to follow-up. 
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Figure 22. BIS total scale scores across baseline, treatment, and follow-up for participant 7. 
Overall, Participant 7 has poor outcomes, suggesting treatment was not successful. 
Child-reported anxiety symptoms on the RCADS, although never “clinically significant,” 
increased from baseline to follow-up. Parent reported Overall Stress on the SDQ remained in 
the borderline range at follow-up. Although Participant 7 no longer met diagnostic criteria for 
generalized anxiety disorder at follow up, a diagnosis of simple phobia and social phobia 
were present at follow-up. Parent-reported functioning indicated a slight decline in functional 
impairment from baseline to follow-up. 
Participant 8 
 Symptoms and diagnosis domain. 
 Child report measure. Participant 8 completed three total assessments (1 baseline, 1 
treatment, and 1 follow-up).  The results of Participant 8’s self-reported levels of depression 
using the Total Depression scale of the Revised Child Anxiety and Depression Scale 
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(RCADS) and represented as overall T-scores are presented in Figure 23. These results 
indicate that Participant 8 experienced her highest level of depression (T-score = 75) at 
baseline. The results also indicate a linear trend towards declining depression symptoms from 
baseline to follow-up. Participant 8’s indicate that her Depression T-scores reached clinical 
significance at baseline. Participant 8’s T-scores were no longer clinically significant at 
treatment or follow-up. 
 
Figure 23. RCADS T-scores across baseline, treatment, and follow-up for participant 8. 
 Parent report measures. The results of Participant 8’s scores of overall stress using 
the Symptoms and Difficulties Questionnaire (SDQ) parent-report and represented as overall 
scale scores are presented in Figure 24. The results indicate that Participant 8’s SDQ scores 
declined from baseline to treatment. The results of Participant 8’s parental reports graph 
indicates Overall Stress scores were in the abnormal range at the baseline assessment and 
75 
62 
40 
20 
30 
40 
50 
60 
70 
80 
B1 T1 F1 
R
C
A
D
S 
D
ep
re
ss
io
n 
T-
Sc
or
e 
Time of Assessment 
RCADS Depression T score Clinical Cutoff 
RCADS Depression Linear Trend 
 70 
decreased to the borderline range at follow-up. These results reveal a downward trend in 
parental report of overall stress from baseline to follow-up.  
 
Figure 24. SDQ Overall Stress scores across baseline, treatment, and follow-up for 
participant 8. 
The initial diagnostic interview using the parent report version of the K-SADS-PL 
indicated that Participant 8’s behavior reached DSM-IV criteria for Major Depression. This 
was the only disorder for which her behaviors reached diagnostic criteria at the initial 
baseline assessment. Results indicate that Participant 8 did not reach diagnostic criteria for 
Major Depression, or for any other DSM-IV disorder at any point during the follow-up 
assessment. 
Functioning Domain. 
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Parent report measure. The results of Participant 8’s parental report of functional 
impairment on the Brief Impairment Scale (BIS) and represented as scale scores are 
displayed in Figure 25. The results demonstrate that Participant 8’s BIS total scale scores 
decline from baseline to the follow-up assessment. Further, these results reveal a linear 
decrease in parental report of functional impairment from baseline to follow-up. 
 
Figure 25. BIS total scale scores across baseline, treatment, and follow-up from participant 8. 
Overall, Participant 8’s treatment outcomes are mixed. For child-reported depression 
symptoms on the RCADS, participant 8 was “clinically significant” at baseline and fell 
below the clinical cutoff at follow-up. Parent reported Overall Stress on the SDQ decreased 
from abnormal scores at baseline to normal scores at follow-up. Participant 8 no longer met 
diagnostic criteria for any DSM-IV disorder. Parent-reported functioning also indicated a 
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slight decline in functional impairment from baseline to follow-up, although the BIS mean 
score (20) at follow up still indicated definite impairment. 
Summary 
An overall summary of participant outcomes and whether they support treatment 
effectiveness is displayed in Table 5. An upward arrow indicates that evidence supports 
treatment effectiveness, a sideways arrow indicates that evidence on treatment effectiveness 
is mixed, and a downward arrow indicates that treatment effectiveness was not supported. In 
order to be considered a success, parent and/or child report measures needed to indicate a 
significant decrease in primary diagnosis symptoms, a decline in functional impairment, and 
no diagnosis at follow-up. A participant is classified as mixed if treatment outcomes indicate 
either a decline in parent and/or child reported symptoms, and/or a decline in functional 
impairment, and/or not meeting diagnostic criteria at follow-up, but not all three. Finally, a 
classification of not successful is made if parent and child report measures failed to indicate a 
decline in primary diagnosis symptoms or indicate an increase in symptoms, if functional 
impairment did not decline or increased, and if the participant still met diagnostic criteria for 
all or some of their intake diagnoses at follow-up. 
Table 4.   
Summary of Participant Outcomes and Treatment Effectiveness for Participant 2 to 8. 
Participant 
Number 
 
# of 
sessions 
Treatment 
Outcome 
Symptoms 
- Child 
Report 
 
Symptoms 
- Parent 
Report 
 
Diagnosis at 
Intake 
 
Diagnosis at 
Follow-up 
Functioning  Therapist 
2 
 
17 Success ⇑ ⇑ Social 
Phobia 
 
No 
Diagnosis 
 
⇑ B 
 73 
Table 4 (continued)  
3 12 Not 
Successful 
⇒ ⇓ Minor 
Depression, 
ADHD, 
ODD 
 
ADHD 
 
⇓ A 
4 
 
12 Success ⇑ ⇑ Panic 
Disorder, 
Separation 
Anxiety 
Disorder 
 
No 
Diagnosis 
 
⇑ B 
5 
 
8 Success ⇑ ⇑ Minor 
Depression 
 
No 
Diagnosis 
 
⇑ B 
6 
 
14 Mixed ⇑ ⇑ Minor 
Depression, 
Enuresis, 
ADHD 
 
Enuresis, 
ADHD 
 
⇑ A 
7 
 
2 Not 
Successful 
⇓ ⇓ Simple 
Phobia, 
Social 
Phobia, 
GAD 
 
Simple 
Phobia, 
Social 
Phobia 
 
 
⇒ A 
8 8 Mixed ⇑ ⇑ Major 
Depression 
No 
Diagnosis 
⇒ B 
 
Discussion 
 In the past few years, primarily due to a growing evidence base of efficacious mental 
health treatments for youth, optimism in the field about transporting evidence based 
treatments into multiple service settings has increased (Weisz et al., 1995; Chorpita & 
Daleiden, 2009. However, issues with transportability and implementation have been 
identified and outcomes from recent attempts to study these treatments outside of research 
settings have been mixed (Southam-Gerow et al., 2010; Weisz et al., 2009). This initial pilot 
transportability study aimed to help move the field further down the path to wide-spread 
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dissemination by implementing a partnership model to adapt evidence-based treatments 
(EBTs) in a community mental health setting using single case design. The goals were to (a) 
demonstrate that adapted EBTs would lead to improvements in client symptoms and 
functioning and (b) provide data to help make adaptations to the EBTs for the third phase of 
the project. The present study addressed these goals by enrolling eight participants with 
various diagnoses (i.e., depression, enuresis, ADHD, simple phobia, social phobia, GAD, 
separation anxiety disorder, panic disorder, ODD) into a single case series. Measurements 
were made at baseline, treatment, and follow-up across two domains, (a) symptoms and 
diagnosis domain (b) and functioning domain. Both parent report and child self-report 
measures were administered. 
 In this next section I will summarize and interpret the results of the single case series 
as well as discuss the implications of the study outcomes. Next, I will discuss the limitations 
of the current study. Finally, future directions will be suggested and the next phase of the 
ADAPT study will be described. 
Interpretation and Summary of Results 
 Altogether, the results of the present study illustrate mixed support for the 
adapted treatment in a community mental health setting as evidenced by differential 
treatment outcomes among the seven participants in Table 5. Treatment outcomes for three 
participants (i.e., 2, 4, 5) were considered a success, whereas two were deemed not successful 
(i.e., 3, 7) and two participant outcomes demonstrated mixed support (i.e., 6, 8). Due to 
unstable baseline trends in some outcome measures and/or some participants not appearing in 
the clinical range of scores at baseline, it was difficult to determine clear treatment effects 
and visual inspection of results became more subjective. However, criteria have been 
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suggested to strengthen the interpretation of clinically significant change such as the 
elimination of the presenting problem and displaying normative levels of functioning at 
follow-up (Jacobson & Truax, 1991). In the current study, success was not only determined 
by trend in the data but also a change from the clinical range of scores to the normal range of 
scores on certain measures from baseline to follow-up, as well as the absence of diagnosis at 
follow-up therefore strengthening interpretation of results. 
 Why did some youth evidence improved outcomes whereas others demonstrated 
mixed or poorer outcomes? Although interpretation of results is limited due to the nature of 
single case design, the data raise two possible hypotheses as to why the study goals were not 
fully supported: (1) cases where participants presented no or fewer comorbidities were more 
successful in treatment, and (2) differences in treatment dose led to differing outcomes 
among the participants.  
Results suggest that treatment was more successful with participants who only met 
diagnostic criteria for one or two DSM-IV disorders versus those participants with multiple 
diagnoses. As stated previously, youth with multiple comorbidities may be more difficult to 
treat than youth that present with only a single DSM-IV disorder (Kazdin & Whitley, 2006). 
EBTs have also been developed in research settings to usually focus on one DSM-IV 
disorder, hence leaving a gap in the evidence base for treatments that work for children with 
multiple comorbidities. The participants in our study who were considered a treatment 
success presented at intake with what may be considered less complex clinical pictures than 
the participants for whom treatment was less successful. For example, two of the cases with 
better outcomes (participant 2 and 5) met criteria for a single DSM-IV internalizing disorder 
and a third case with a strong outcome (participant 4) met criteria for two DSM-IV 
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internalizing disorders. The participants with the poorest outcomes, on the other hand, had 
what appear to be more complex clinical presentations when judged by presence of DSM-IV 
disorders. Both cases with the poorest outcomes (participant 3 and 7) met criteria for three 
DSM-IV disorders, one of which had a mixed internalizing and externalizing diagnostic 
picture. The two participants with mixed outcomes provide some additional support to the 
hypothesis that multiple comorbidities negatively affected treatment outcomes because one 
participant presented at intake with no comorbidities (participant 8), whereas one participant 
presented at intake with three comorbid disorders (participant 6).  In participant 8’s case, 
symptoms and diagnosis domain measures indicated treatment gains, whereas the functioning 
domain measure demonstrated continued functional impairment at follow-up. In other words, 
of the two cases with mixed outcomes, the least complex clinical case, participant 8, had a 
better outcome than the more complex case, participant 6. It is worth noting though that 
participant 6, despite demonstrated treatment gains in symptoms and functioning, continued 
to demonstrate behavior indicative of two DSM-IV diagnoses at all follow-up assessments, 
suggesting the possibility that multiple comorbidities decreased treatment effects. Taken 
together, these results suggest that complexity and/or severity of the presenting problem, and 
in particular comorbid externalizing symptomatology, may account for the diminished 
treatment gains observed in the present study, a result consistent with past work (Rohde, 
Clarke, Mace, Jorgensen, & Seeley, 2004; Garcia et al., 2010).  
Externalizing symptomatology as a moderator of treatment has also been illustrated in 
the current child treatment literature. In an randomized controlled study of cognitive-
behavioral treatment for adolescents with major depression and comorbid conduct disorder, 
treatment was found to be effective at reducing depressive symptoms but not effective at 
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reducing symptoms of conduct disorder (Rohde et al., 2004). In an OCD treatment study, 
where youths were randomized to one of three treatment groups (CBT-only, SSRI-only, 
CBT/SSRI), outcomes indicated that youth with higher levels of externalizing symptoms 
fared worse across all treatment conditions relative to peers with lower levels of externalizing 
symptoms (Garcia et al., 2010). In contrast, treatment studies for youth anxiety have 
indicated no treatment differences for youth with comorbid externalizing symptomatology 
(Flannery-Schroeder, Suveg, Safford, Kendall, & Webb, 2004; Verduin & Kendall, 2003). 
However, both of these study samples had few youth with comorbid disruptive behavior 
disorders and evidence has demonstrated that anxiety research clinic populations have a 
significantly lower incidence of comorbid externalizing disorders than community clinic 
samples (Southam-Gerow et al., 2006; 2008). Overall, the treatment literature indicates 
support for the current study’s hypothesis that externalizing symptomatology may account 
for decreased treatment gains. 
Severity of presenting problem is another potential moderator of treatment outcomes 
that has been supported in the child treatment literature (Southam-Gerow et al., 2001; 
Berman, Weems, Silverman, & Kurtines, 2000; Salzer, Bickman, & Lambert, 1999). In an 
analysis of archival data using participant information from the Fort Bragg Evaluation 
Project, Salzer and colleagues (1999) found that clients who were in treatment longer had 
significantly more problems and more severe problems at intake. Similarly, Berman and 
colleagues (2000) examined predictors of exposure-based CBT for phobic and anxiety 
disorders in youth and found that children with a comorbid diagnosis of depression were 
more likely to demonstrate diminished treatment gains than children without comorbid 
depression. A study on youth with anxiety disorders also found that increased levels of 
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mother- and teacher-reported child internalizing symptoms were significantly related with 
poorer treatment outcomes (Southam-Gerow et al., 2001). 
Another third and final factor that may explain the mixed outcomes observed in the 
present study is treatment dose or length. Treatment length for participants who were 
considered a treatment success attended between 10 to 17 sessions with a mean of 13, 
whereas participants who evidenced mixed treatment gains attended between 8 to 14 
sessions, with a mean of 11, and those who did not experience treatment gains attended 
between 2 to 12 sessions, with a mean of 7 sessions. The literature on treatment dose for 
child psychotherapy, although scant, illustrates mixed findings on the effect of dose on 
treatment outcomes. For example, treatment outcomes in a Parent-Child Interaction Therapy 
(PCIT) follow-up study indicated that parents who completed treatment experienced 
significantly better outcomes than parents who dropped out of treatment (Boggs et al., 2004). 
Important to note is that no pretreatment differences were found for demographic or clinical 
characteristics between the “completer” group and the “dropout” group. In a meta-analysis of 
child therapy treatment studies, Jensen and colleagues found that 13 out of 27 studies since 
1995 demonstrated a significant difference among similarly intensive treatment groups 
illustrating that treatment dose makes a difference in outcomes (Jensen, Weersing, 
Hoagwood, & Goldman, 2005). On the other hand, Salzer, Bickman, and Lambert found no 
general treatment dose effect when looking at this effect in archival data of 567 children who 
participated in the Fort Bragg Evaluation Project (1999). Despite these findings on the effects 
of treatment dose, Hoagwood (2000) stated that differences in the way “dose” is defined, 
measured, and analyzed disguises the fact that an important part of child treatment 
development, identifying the mechanisms of action, is missing (2000). To measure dose 
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accurately, it is important to know why a particular therapeutic approach has its intended 
effect. Not until we know how treatment works can we begin to recommend at what dose it is 
most effective. Essentially, appropriate treatment dose could be different depending on 
diagnosis, treatment used, environmental factors, age, gender, etc. (Salzer et al., 1999). 
Implications 
The results of this study demonstrate the challenges in using EBTs in novel 
community clinic settings. Focus of treatment varied greatly for each participant, depending 
on diagnostic profile at intake as well as the therapist’s case conceptualization for each case. 
One implication of the adaptations of the EBTs, although allowing for individualization of 
treatment for each youth, is that efficacy cannot be assumed due to the adaptations that were 
made. In addition, this study illustrates the need to consider if and how treatment dose affects 
treatment outcomes, especially at a time when many healthcare companies want to impose 
limits and restrictions on mental health services (Andrade, Lambert, & Bickman, 2000). 
Research into ways of decreasing attrition among youth and families in community clinic 
settings could allow for further adaptations of EBTs in these settings (Miller, Southam-
Gerow, & Allin, 2008). It is also important to determine the typical number of sessions 
needed for maximum effectiveness for a particular type of client and for a particular type of 
problem (Salzer et al., 1999). 
Furthermore, outcomes for the symptoms and diagnosis domain suggest that cases 
with mixed internalizing/externalizing presentations might require further adaptation. 
Although treatment in mixed presentation cases followed both internalizing and externalizing 
EBT manuals, the focus of treatment were the internalizing disorder diagnoses. Other 
researchers have demonstrated alternative approaches to incorporating externalizing 
 80 
symptomatology and other comorbidities in treatment programs. The modular approach 
developed by Chorpita and colleagues (Chorpita, 2007; Chorpita, Daleiden, & Weisz, 2005) 
allows for the “preservation of standard protocol when necessary,” but would also allow for 
scaling and/or adaptations as needed. The modular approach to treatment consists of self-
contained “modules” that connect with other “modules,” but can be used at any time 
throughout treatment and do not rely on a certain “module” needing to be presented before it 
or after it (Chorpita et al., 2005). This flexible adaptability allows for easier transportability 
into different settings and increased individualization for each client. Similar to the current 
study, the modular approach builds the treatment plan around a youth’s primary diagnosis. 
Weiss and colleagues (Weiss, Harris, Catron, & Han, 2003) developed an intervention 
designed to treat concurrent internalizing and externalizing disorders in youth called 
Reaching Educators, Children and Parents program (RECAP). RECAP is a combination of 
modified treatment techniques (coping skills training, problem-solving skills training, parent 
training) that were chosen to target factors believed to be responsible for maintaining both 
child internalizing and externalizing problems. The treatment plan is not driven by the 
youth’s primary diagnosis, but is designed to target these three specific domains that affect 
both internalizing and externalizing symptoms. Continued research with treatments for 
children with comorbid disorders is needed to assess why and how externalizing comorbidity 
affects outcomes and how best to address cases in which the client has multiple problems.  
The present results also illustrated that all participants, regardless of overall treatment 
gains or lack thereof, demonstrated some improvement over the course of treatment whether 
in symptoms and diagnosis or functioning. This contributes to the current literature that 
recommends assessing not only the symptom and diagnosis domain in treatment studies, but 
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also other domains (e.g., functioning) to get a more complete picture of how the youth is 
responding to treatment (Becker, Chorpita, & Daleiden, 2011; Hoagwood et al., 1996; Weiss 
et al., 2003). Functional impairment is a necessary criterion for diagnosing a youth with a 
DSM-IV diagnosis (APA, 2000).  
In short, this study represents an initial step in a larger project aimed at testing the 
utility of a partnership model for adapting EBTs for youth in a community clinic setting. The 
findings of this study suggest some useful hypotheses to test in a larger scale study. 
Specifically, participants who did not present with a comorbid disorder benefited from 
treatment elements not ordinarily found in one standard manual (e.g., communication skills 
training for the family in treatment for depression).  
Limitations 
There are limitations to this study to consider. The most pressing concern is the 
limited ability to generalize findings to other populations and/or other clinic settings. Kazdin 
(1982) stated that generality is not necessarily a problem for single case studies in that visual 
inspection detects dramatic intervention effects that may be more likely to generalize than 
more subtle effects detected by between-group designs. On the other hand, difficulty in 
assessing elements of treatment that may relate to generality, such as therapist (e.g., 
treatment adherence, treatment competence) and/or participant variables (e.g., gender, age) 
are more appropriately evaluated in a between-group design. However, a single case design 
study that is used as a preliminary test of a new or adapted treatment could allow researchers 
to develop hypotheses about the study results and test those hypotheses in a larger group 
design. Another limitation that affected generalizability was the heterogeneity of youths, 
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including multiple comorbidities, which could have undermined treatment focus on the 
youth’s primary diagnostic problem. 
The use of randomization to determine the number of baseline assessments for each 
participant also limited interpretation of results. Performance during baseline assessments is 
used to predict how the youth may continue to behave without intervention so it is important 
to demonstrate a stable rate of performance in this phase (Kazdin, 1982). In some outcome 
measures (e.g., Figure 1), a participant may have demonstrated a baseline trend in the same 
direction that the intervention produced, hence interfering with the ability to determine clear 
treatment effects. In order to control for trends in baseline, some have suggested a data based 
baseline determination procedure where the treatment phase is only introduced when the data 
show no trend in the baseline phase (Koehler & Levin, 1998). Another option suggested is to 
randomize intervention introduction once a stable baseline has been achieved. Statistical 
analyses also may allow for the evaluation of effects by accounting for the initial trend in the 
baseline data (Kazdin, 1982). In the current study, the clinic required that the youth wait no 
longer than one month for treatment, hence not allowing for a data based baseline 
determination.  
The issue of clinical significance was another challenge that arose in interpretation of 
results. Due to the shortened baseline period, certain measures (e.g., CBCL) were 
administered at shorter intervals than recommended for re-administration. For example, it is 
recommended that the CBCL only be administered every one to two months, but it was 
administered every one to two weeks during the baseline phase of the current study 
(Achenbach & Rescorla, 2004). Due to unstable baseline trends in some outcome measures 
and/or some participants not appearing in the clinical range of scores at baseline, it was 
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difficult to determine clear treatment effects and visual inspection of results became more 
subjective. Criteria have been suggested to strengthen the interpretation of clinically 
significant change such as the elimination of the presenting problem and displaying 
normative levels of functioning at follow-up (Jacobson & Truax, 1991).  
Another limitation or challenge that was faced throughout the study was engaging 
participants in recruitment and continuous assessment. Inclusion criteria for the study 
initially indicated recruiting participants with an internalizing disorder and comorbid 
externalizing symptomatology, unfortunately due to time constraints and a lack of available 
cases, children who only had internalizing behavior problems were included as well. Last, 
participants and their families often had trouble attending the multiple and sometimes lengthy 
assessments, was difficult, especially once a participant had terminated treatment. Due to 
this, assessments did not always occur according to schedule. A related issue that limited the 
study findings was missing data. Due to difficulty scheduling assessments, some participants 
did not have any data for certain assessment points and/or assessments were shortened and 
not all measures administered due to participant time constraints. Creating multiple avenues 
for data collection including an online assessment tool that would allow families to complete 
measures at their convenience could increase engagement. Another option could be having 
the therapists administer certain measures to the youth and family at the time of their 
treatment session, thus eliminating the need to come back to the clinic for multiple 
assessment sessions. The measurement model also shifted throughout the single case study, 
which caused us to have measures for certain assessment phases and not others making data 
interpretation difficult.  
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Finally, adapting efficacious treatments runs the risk of removing or diluting the 
important ingredients. Since different treatment elements were being used out of different 
manuals in a non-standard sequence, the treatments were not the same ones that were 
efficacious in research settings. The therapists at the clinic were allowed to individualize the 
treatment based on their conceptualization of what the youth and his or her family needed, in 
consultation with the study supervisor. This limited our ability to interpret findings in relation 
to which treatment elements worked and did not work and how best to sequence certain 
treatment elements. Although used in a non-standard fashion, the treatment plans were 
guided by a reliance on EBTs, and the quality of the sequence and treatment delivery was 
monitored in supervision. 
Future Directions 
 The results of the study suggest many important directions for future scientific work 
related to the transportability of EBTs into community clinics and other service clinic 
settings. One important issue is how best to adapt treatments to ensure positive treatment 
outcomes for youth with comorbid disorders, especially youth that present with comorbid 
internalizing and externalizing symptomatology. These results suggest that the tested method 
of supplementing EBTs for anxiety or depression with elements from an EBT for 
externalizing disorders was not effective. Similar to RECAP (Weiss et al., 2003) described 
earlier, perhaps using a treatment that focuses more generally on factors that perpetuate both 
internalizing and externalizing symptoms would lead to better outcomes for youth with 
comorbid presentations in community clinics. Studies could also increase representation of 
youth with externalizing comorbidity to determine how best adaptations could be made to 
increase treatment gains in this population. 
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Future studies could also consider the cost-effectiveness of training community 
therapists on the adapted treatment. The current study uses an expert in the community to 
train the community therapists and supervise all of the cases; unfortunately, this opportunity 
is not always available for many community clinics so accessibility to training tools and 
therapy manuals is necessary for the widespread dissemination of these adapted treatments 
into multiple settings (Addis, 2002).  
 Another suggestion for measuring successful adaptation of treatments in community 
clinics would be to measure therapist competence and adherence with the adapted EBTs. For 
the next phase of the current study, the open trial phase, a modular approach to treatment, as 
described earlier, will be implemented. Most current EBTs are considered as “integral” 
approaches to treatment, defined as parts functioning as a single whole creating a high level 
of interdependence among each part, therefore although these “integral” manuals can be 
divided into individual sessions, the sessions do not stand alone and ordinarily have to be 
presented to a client in a certain order. This flexible adaptability of the modular approach 
may allow for easier transportability, increased individualization for each client, and is more 
comprehensible for therapists since one “module” can be studied at a time. The next phase of 
ADAPT will allow us to test the hypotheses raised in the current study. The treatment 
approach in the open trial phase allows for a better integrated approach to deal with youth 
with comorbid disorders. Feedback from the therapists’ experience in the current study also 
help to guide efforts for the next phase, for example, in the addition of new treatment 
modules (e.g., communication, emotion regulation). Using a more “formal” approach to 
adaptation might allow for more robust effects in future studies, allowing better measurement 
of client and therapist factors that affect treatment outcome. Knowing these factors could 
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lead to better adaptations in treatment as well as increased implementation for diverse 
populations and clinic settings.  
Overall, the results of the single case series provided preliminary, though somewhat 
mixed, support for both the adapted treatment approach and the partnership model that is part 
of the broader ADAPT project. Continued research in (1) how best to address comorbid 
externalizing symptoms and/or severity of diagnosis and (2) how to improve retention and 
increase treatment dose, will eventually lead to better adaptations of EBTs and allow for 
increased implementation of EBTS with diverse populations and settings. 
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